Sterilization indicator test packs

ABSTRACT

Sterilization indicator test packs for testing the effectiveness of a sterilization procedure are provided. Both non-challenge and challenge-type test packs are disclosed. The non-challenge test packs include generally comprise a tray for holding a sterilization indicator the tray containing an elevated rim surface defining the perimeter of the tray and a recessed trough for receiving a sterilization indicator. The rim surface includes a plurality of spaced-apart grooves along its length extending through the rim to the recessed trough; a sterilization indicator within the recessed trough of the tray; and a lid that forms a plurality of channels with the grooves in the tray such that sterilant can enter the tray through the channels and contact the sterilization indicator. 
     The challenge-type test packs generally include a tray for holding a sterilization indicator, the tray comprising a substantially planar surface, a recessed trough for receiving a sterilization indicator, and a recessed groove of a defined length and cross-sectional area extending through the recessed trough and penetrating the edge of the tray; a sterilization indicator within the recessed trough of the tray; and a lid forming a substantially sterilant-impermeable seal with the planar surface of the tray and forming a lumen path with the recessed groove in the tray.

CROSS-REFERENCE TO OTHER APPLICATIONS

This application is a continuation-in-part of application 10/014,736 now filed Dec. 11, 2001 U.S. Pat. No. 6,897,059 B2, issued on May 24, 2005, which is a divisional of application 09/228,712 now filed Jan. 12, 1999 U.S. Pat. No. 6,355,448 B1 , issued Mar. 12, 2002, which is a continuation-in-part of U.S. application Ser. No. 09/088,859, filed Jun. 2, 1998, now abandoned.

FIELD OF THE INVENTION

The present invention relates to sterilization indicators for testing the effectiveness of a sterilization procedure, and in particular to sterilization indicators that measure the activity of an enzyme whose activity is correlated with the survival of microorganisms.

BACKGROUND

Sterilization indicators provide a means for determining whether a sterilizing machine, such as those used to sterilize surgical instruments in hospitals, is functioning properly and killing microorganisms that are present in the sterilization chamber during a sterilization procedure.

Biological indicators are recognized in the art as providing an accurate and precise means for testing the effectiveness of a sterilization procedure. Conventional biological indicators gauge the effectiveness of a sterilization procedure by monitoring the survival of a test microorganism contained within the biological indicator that is many times more resistant to the sterilization process than most organisms that would ordinarily be present by natural contamination. The biological indicator is exposed to a sterilization cycle and then incubated under conditions that will promote the growth of any surviving test microorganisms. If the sterilization cycle fails, the biological indicator generates a detectable signal indicating that the biological specimen survived. The detectable signal is commonly an indication such as a color change or the emission of a luminescent or fluorescent signal.

One well-known type of biological indicator employs spores from bacteria or fungi, which are very resistant to sterilization, to test the effectiveness of a sterilization procedure. U.S. Pat. No. 3,661,717 (Nelson) discloses a self-contained biological indicator for monitoring the effectiveness of a sterilization procedure by measuring the survival of a test population of spores. The biological indicator has an outer tube made of a compressible, plastic material and a sealed inner tube made of a breakable material such as glass. A bacteria impermeable, gas transmissive covering on the outer tube allows sterilant to enter the outer tube during a sterilization procedure. Live spores on a piece of carrier material are located between the walls of the outer tube and the inner tube. The inner tube contains a growth medium that stimulates the growth of live spores. During the sterilization procedure sterilant enters the outer tube through the cap and contacts the spores on the carrier strip. After the sterilization procedure, the inner tube is crushed by compressing the outer tube, releasing the growth media and bringing it into contact with the spores on the carrier strip. The indicator is then incubated under conditions that stimulate spore growth. If the sterilization procedure is ineffective, surviving spores will grow out and cause a pH indicator in the growth medium to change color, indicating that the sterilization cycle failed to kill the test population of microorganisms and may have failed to kill contaminating microorganisms present in the sterilizer load. Although biological indicators that rely on the growth of spores are accurate, they are slow, commonly requiring between 1 and 7 days to provide final results. During this incubation period the goods exposed to the sterilization procedure should preferably be quarantined until final indicator results are obtained. However, holding goods in quarantine for such a lengthy period of time requires a substantial commitment of space that could otherwise be used for other purposes, and complicates the efficient regulation of inventory.

Recently sterilization indicators have been developed that measure the effectiveness of a sterilization procedure by measuring the activity of an enzyme whose activity is correlated with the destruction of contaminating microorganisms during a sterilization procedure. Enzyme sterilization indicators are disclosed in U.S. Pat. Nos. 5,252,484 and 5,073,488. In contrast to biological indicators that measure spore growth alone, enzyme indicators provide a rapid answer, often in a matter of a few hours. The indicators have a compressible outer tube, a breakable inner tube, and a cap that is bacteria impermeable but gas trasmissive. Active enzyme is impregnated on a carrier strip located between the walls of the outer and inner containers, and a substrate that reacts with the active enzyme is contained within the sealed inner tube. During the sterilization procedure the sterilant enters the outer tube and contacts the active enzyme on the carrier strip. After the sterilization procedure, the inner vial is crushed and the enzyme strip is exposed to the substrate and incubated. If the sterilization procedure works properly, the enzyme is inactivated during the procedure and there is no detectable change following incubation. However, if the sterilization procedure is ineffective, the enzyme is not inactivated and will react with the substrate to form a detectable product. The enzyme-substrate product may be detectable as a color change or as a fluorescent or luminescent signal.

Dual rapid readout indicators are sterilization indicators that test the effectiveness of a sterilization procedure by measuring both enzyme activity and spore growth following exposure to a sterilization procedure. The enzyme system gives a rapid indication of the effectiveness of a sterilization cycle, which is then confirmed by measurement of spore outgrowth over a longer period of time. In a dual rapid readout indicator, the live spores utilized in the spore outgrowth portion of the indicator may also serve as the source of active enzyme for the enzyme activity portion of the assay. The rapid enzyme test measures the activity of an enzyme that is associated with the spores, and the spores themselves are then incubated to encourage the outgrowth of any spores that survived the sterilization procedure. 3M™ Attest™ 1291 and 1292 Rapid Readout Biological Indicators, available from 3M Company, St. Paul, Minn., are dual rapid readout indicators that test the effectiveness of a sterilization cycle by measuring both the activity of an enzyme associated with Bacillus stearothermophilus spores in the indicator and the survival of the spores themselves.

Although enzyme sterilization indicators are both rapid and accurate for testing the effectiveness of most steam sterilization procedures, the enzyme in an indicator may be prematurely inactivated before all of the contaminating microorganisms have been killed when certain prevacuum, or vacuum assisted, steam sterilization procedures are used. As a result, the sterilization indicator may provide an incorrect indication that the sterilization procedure was effective, or a “false negative” result. The existence of the premature inactivation problem has been detected with dual rapid readout indicators, which after exposure to a suspect sterilization procedure provide a negative result by the enzyme test and a contradictory positive result by the spore growth test. Premature inactivation of enzyme in sterilization indicators has been observed, and is known to be a problem, with 121° C. prevacuum sterilization cycles in which a vacuum is drawn in the sterilization chamber before stream is introduced. Although the precise mechanism underlying this problem is not known with certainty, it is believed that it may be caused by condensed sterilant contacting the enzyme and inactivating it.

Premature inactivation of enzyme has also been observed in dual rapid readout indicators that have been exposed to hydrogen peroxide plasma sterilization procedures. Sterilization processes using hydrogen peroxide plasma are known in the art and are described, for example, in U.S. Pat. No. 4,643,876, issued to Jacobs et al. Plasma refers to the portion of the gas or vapors of a sterilant that includes electrons, ions, free radicals, dissociated atoms and molecules that are produced when an electrical field is applied to the sterilant, and includes any radiation produced by the sterilant after application of the electrical field. In hydrogen peroxide plasma sterilization procedures, a vacuum is typically drawn in a sterilization chamber and hydrogen peroxide vapor is injected and allowed to diffuse throughout the chamber and contact the surfaces of all items that are intended to be sterilized. A vacuum is then drawn to remove the hydrogen peroxide vapor, and a plasma is generated within the chamber by an electrical power source, such as a radio frequency (RF) power source. The power is continued for a period of time sufficient to create a plasma that kills any microorganisms within the chamber. The precise mechanism responsible for premature inactivation in hydrogen peroxide plasma sterilization procedures is not known.

Efforts have been made in the art to prevent premature inactivation of enzyme in sterilization indicators. Commonly assigned U.S. patent application Ser. No. 08/954,218 (Albert) discloses a protective housing that impairs the premature inactivation of enzyme in an enzyme indicator or a dual rapid readout indicator by preventing condensed sterilant from contacting the indicator. The protective housing includes a tube to contain a biological indicator and a cap assembly designed to prevent condensed sterilant from contacting the biological indicator within the tube. The cap assembly includes an aperture through which non-condensed sterilant may enter the housing to contact the biological indicator. An absorbent material within the cap assembly retains condensed sterilant and inhibits fluid from entering the tube and contacting the biological indicator, yet allows noncondensed sterilant to enter the housing. Thus, the Albert application prevents premature inactivation indirectly, by providing a physical barrier that prevents condensed sterilant from contacting the enzyme.

There is a need in the art for an enzyme-based sterilization indicator in which the enzyme is made resistant to premature inactivation by a chemical treatment.

SUMMARY OF THE INVENTION

The present invention provides various embodiments of sterilization test packs useful for testing the effectiveness of a sterilization procedure. The sterilization test packs of the invention broadly fall in two categories: “non-challenge” test packs and “lumen-challenge” test packs.

A non-challenge test pack holds a sterilization indicator in place but provides substantially no increased resistance, or “challenge,” to a sterilization procedure. The non-challenge test pack generally includes a tray, a sterilization indicator, and a lid. The tray includes an elevated rim defining the perimeter of the tray and a recessed trough for holding a sterilization indicator. The rim includes a plurality of grooves that extend through the rim to the recessed trough. When the lid is placed on the tray, it forms a substantially sterilant-impermeable seal with the rim surface and forms a plurality of channels with the grooves in the rim. When a non-challenge test pack is subjected to a sterilization procedure, sterilant travels through the channels and contacts the sterilization indicator within the tray.

A lumen-challenge test pack increases the resistance of the sterilization indicator to a level that is equivalent to the resistance that would be experienced if the sterilization indicator were placed within a lumen having a defined length and cross-sectional area. The lumen-challenge test pack generally comprises a tray for holding a sterilization indicator, a sterilization indicator and a lid. The tray includes a substantially planar surface with an edge that defines the outer perimeter of the tray, a recessed trough for holding the sterilization indicator, and a recessed groove of a defined length and cross-sectional area extending through the trough and penetrating the edge of the tray at at least one (generally two) points. When the lid is placed on the tray, a substantially impermeable seal is formed between the lid and the substantially planar surface of the tray, and a lumen path is formed between the lid and the recessed groove of the tray. During a sterilization procedure, sterilant may enter the test pack through the lumen path and contact the sterilization indicator.

In other aspects, the invention addresses the problem of premature inactivation of enzymes in enzyme-based sterilization indicators by providing a sterilization indicator in which the source of active enzyme has been treated with a sterilant-resistant chemical. The sterilization indicator of the invention comprises a source of active enzyme, a sterilant-resistant chemical associated with the source of active enzyme, and a substrate that is capable of reacting with the active enzyme to form an enzyme-modified product that provides a detectable indication of the failure of a sterilization procedure.

In one embodiment of the invention, the sterilant-resistant chemical may be a polyglycerol alkyl ester or a polyglycerol alkyl ether. In another embodiment the sterilant-resistant chemical may be an ethoxylated polyhydric alcohol ester or an ethoxylated polyhydric alcohol ether.

In a preferred embodiment of the invention, the sterilization indicator is a self-contained biological indicator in which the enzyme has been chemically treated to enhance its resistance to premature inactivation. The biological indicator comprises a compressible outer container, a breakable inner container, a source of active enzyme associated with a sterilant-resistant chemical, and a substrate that is capable of reacting with the enzyme to form an enzyme-modified product that provides a detectable indication of the failure of a sterilization procedure. The outer container has at least one opening to allow sterilant to enter the outer container during a sterilization procedure. The inner container is sealed at both ends and contains the reactive substrate. The source of active enzyme is located between the walls of the outer container and the inner container.

The invention also provides a method for testing the effectiveness of a sterilization procedure using a sterilization indicator made with spores that have been treated with a sterilant-resistant chemical. The method comprises the steps of providing a sterilization indicator, subjecting the sterilization indicator to a sterilization procedure, combining the enzyme and substrate within the sterilization indicator, and examining the sterilization indicator for a detectable signal indicating the failure of the sterilization cycle.

In addition, the invention provides a sterilization indicator for specific use in a hydrogen peroxide plasma sterilization procedure in which the enzyme has been chemically treated to enhance its resistance to premature inactivation. The sterilization indicator includes a source of active enzyme, a sterilant-resistant chemical associated with the source of active enzyme, and a substrate that is capable of reacting with the active enzyme to form an enzyme-modified product that provides a detectable indication of the failure of a sterilization procedure. In this embodiment, the sterilant-resistant chemical is preferably selected from the group consisting of decaglyceryl decaoleate, decaglycerol pentaoleate, tetraglycerol monooleate, decaglyceryl tri-oleate, decaglycerol hexaoleate, hexaglycerol dioleate, polyoxyethylene (60) glycerol monostearate, polyoxyethylene (20) sorbitan monostearate, and hexaglyn di-stearate.

In a preferred embodiment, the sterilization indicator for use in hydrogen peroxide plasma procedures is a self-contained biological indicator. The indicator employs a source of active enzyme that has been chemically treated to enhance its resistance to premature inactivation. The self-contained biological indicator comprises a compressible outer container, a breakable inner container, a source of active enzyme associated with a sterilant-resistant chemical, and a substrate that is capable of reacting with the enzyme to form an enzyme-modified product that provides a detectable indication of the failure of a sterilization procedure. The outer container has at least one opening to allow sterilant to enter the outer container during a sterilization procedure. The inner container is sealed at both ends and contains the reactive substrate. The source of active enzyme is located between the walls of the outer container and the inner container.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1 is an exploded view of a preferred embodiment of a sterilization indicator of the invention

FIG. 2 is a cross-sectional view of the device shown in FIG. 1.

FIG. 3 is a graph depicting the change in pressure over time in a pre-vacuum steam sterilization cycle in which steam is introduced into the sterilization chamber before a vacuum is drawn.

FIG. 4 is a graph depicting the change in pressure over time in a pre-vacuum steam sterilization cycle in which a vacuum is drawn in a sterilization chamber before steam is injected.

FIG. 5 is a graph depicting the change in pressure over time in a pre-vacuum steam sterilization cycle in which a series of vacuum pulses are drawn in the chamber before steam is injected.

FIG. 6 is an exploded view of an alternative preferred embodiment of the sterilization indicator of the invention.

FIG. 7 is cross-sectional view of the device shown in FIG. 6.

FIG. 8 is a perspective view of a preferred embodiment of the non-challenge test pack of the invention.

FIG. 9 is a perspective view of one embodiment of a lumen-challenge test pack of the invention.

FIG. 10 is a perspective view of an alternative embodiment of a test pack of the invention.

FIG. 11 is a perspective view of another alternative embodiment of a test pack of the invention.

FIG. 12 is a perspective view of another alternative embodiment of a test pack of the invention.

FIG. 13 is a perspective view of another alternative embodiment of a test pack of the invention.

DETAILED DESCRIPTION OF THE INVENTION

The sterilization indicators of this invention address a problem experienced with biological indicators that use enzymes to test the effectiveness of sterilization procedures, such as the enzyme sterilization indicators and dual rapid readout indicators described in U.S. Pat. No. 5,252,484 and U.S. Pat. No. 5,073,488, which are incorporated in their entirety herein by reference. In particular, in one embodiment of the invention, the sterilization indicators are designed to alleviate the problem of premature inactivation of enzyme in a sterilization indicator. This objective is accomplished by treating the spores used as a source of active enzyme with a sterilant-resistant chemical before assembling the indicators.

Although enzyme sterilization indicators are used in several different types of sterilization cycles, premature inactivation of enzyme is not a problem with all of them. It is primarily a problem with regard to a particular class of pre-vacuum sterilization procedure in which a vacuum is drawn in the sterilization chamber before steam is introduced. A pre-vacuum sterilization cycle is one in which a vacuum-driven conditioning phase is used before the chamber reaches sterilization temperature.

FIGS. 3–5 are graphs that depict the change in pressure over time in three different pre-vacuum sterilization procedures that are commonly used. The procedure represented in FIG. 3 is one that is not prone to cause premature inactivation of enzymes and false negatives in enzyme sterilization indicators. In this procedure, steam is injected into the sterilization chamber before a vacuum is exerted. The initial pressure during the sterilization cycle is positive relative to atmospheric pressure as steam is injected into the sterilization chamber but then becomes negative relative to atmospheric pressure as a vacuum is exerted in the chamber. When an enzyme sterilization indicator is exposed to a sterilization cycle such as the one shown in FIG. 3, the enzyme should be inactivated shortly after the spores have been killed. In the pre-vacuum steam procedures that are most commonly used in the United States, steam is injected into the sterilization chamber before a vacuum is exerted.

In contrast, FIGS. 4–5 depict two pre-vacuum steam sterilization procedures in which a vacuum is drawn in the sterilization chamber before steam is introduced. These procedures, which are commonly used in Europe, are prone to cause the premature inactivation of enzyme and false negatives in enzyme sterilization indicators. In the sterilization procedure represented in FIG. 4, the pressure in the sterilization chamber becomes negative relative to atmospheric pressure as a vacuum is drawn prior to the introduction of steam. In the sterilization cycle represented in FIG. 5, four pulses of vacuum are drawn in the chamber followed by steam injection before the chamber reaches sterilization temperature. Although the precise mechanism of the inactivation of enzyme in these cycles is not known with certainty, and the applicant does not wish to be bound by any particular theory of operation, it is believed that the enzyme may be inactivated when it is contacted with condensed sterilant.

One representative sterilization indicator of the invention is shown in FIGS. 1 and 2. The sterilization indicator 10 includes nesting containers that separate the various components of the system from each other until after the sterilization cycle is complete. The sterilization indicator 10 includes an outer tube 12, a sealed inner tube 18 and a vented cap 26. Outer tube 12 is preferably made of a compressible plastic. Inner tube 18 is made of glass or some other frangible material. Closure member 22 is preferably a bacteria impermeable, gas transmissive barrier that fits over the open end 14 of outer tube 12. Carrier strip 16 includes on its surface a source of active enzyme, either microorganism spores or a purified enzyme, and is disposed between the walls of the inner tube 18 and the outer tube 12. The source of active enzyme has been treated with a sterilant-resistant chemical to prevent premature inactivation of the enzyme during a sterilization cycle. Inner tube 18 contains a substrate that reacts with the enzyme on carrier strip 16 and creates a detectable signal if the sterilization procedure is ineffective.

During a sterilization procedure sterilant enters the outer tube 12 through the vents 28 on cap 26 and contacts the source of active enzyme on carrier strip 16 but does not contact the substrate solution in the sealed inner tube 18. After the sterilization cycle the sides of the outer tube 12 are compressed, breaking the inner tube 18 and bringing the enzyme and substrate into contact with each other. The sterilization indicator is then incubated for a period of time sufficient for any remaining active enzyme to react with the substrate to form an enzyme-modified product that produces a detectable signal, such as luminescence, fluorescence or a color change, indicating that the sterilization procedure may have been ineffective.

In one embodiment of the sterilization indicator 10 of the invention, the source of active enzyme on carrier strip 16 is a live microorganism, such as a bacterial or fungal spore. In one preferred embodiment, spores are the source of active enzyme, and the sterilization indicator 10 is a dual rapid readout indicator that monitors the effectiveness of a sterilization procedure by measuring both enzyme activity and spore outgrowth. In this embodiment, the inner tube 18 contains spore growth medium and enzyme substrate. After the sterilization cycle is complete, the inner tube 18 is broken, and the carrier strip 16 is exposed to its contents and incubated. The enzyme test produces visible results within a few hours, and the live microorganism growth test confirms these results within 7 days.

The theory underlying the operation of enzyme indicators is that the inactivation of the enzyme will be correlated with the death of test microorganisms in the indicator. The enzyme selected for use in a biological indicator must be at least as resistant to a sterilization procedure as microorganisms that are likely to be present as contaminants, and preferably more resistant than such microorganisms. The enzyme should remain sufficiently active to form a detectable enzyme-substrate product after a sterilization cycle that fails to kill contaminating microorganisms, yet be inactivated by a sterilization cycle that kills contaminating microorganisms.

Enzymes and substrates that are suitable for use in the sterilization indicators of the invention are described in U.S. Pat. No. 5,252,484 and U.S. Pat. No. 5,073,488. Suitable enzymes include enzymes derived from spore-forming microorganisms, such as Bacillus stearothermophilus and Bacillus subtilis. Enzymes from spore-forming microorganisms that are useful in the biological indicators of the invention include beta-D-glucosidase, alpha-D-glucosidase, alkaline phosphatase, acid phosphatase, butyrate esterase, caprylate esterase lipase, myristate lipase, leucine aminopeptidase, valine aminopeptidase, chymotrypsin, phosphohydrolase, alpha-D-galactosidase, beta-D-galactosidase, tyrosine aminopeptidase, phenylalanine aminopeptidase, beta-D-glucuronidase, alpha-L-arabinofuranosidase, N-acetyl-B-glucosaminodase, beta-D-cellobiosidase, alanine aminopeptidase, proline aminopeptidase and a fatty acid esterase, derived from spore forming microorganisms.

Chromogenic and fluorogenic substrates that react with enzymes to form detectable products, and that are suitable for use in the sterilization indicator of the invention, are well known in the art. (M.Roth, Methods of Biochemical Analysis, Vol. 17, D. Block, Ed., Interscience Publishers, New York, 1969, p. 89; S Udenfriend, Fluorescence Assay in Biology and Medicine, Academic Press, New York, 1962, p. 312; D. J. R. Lawrence, Fluorescence Techniques for the Enzymologist, Methods in Enzymology, Vol. 4, S. P. Colowick and N. O. Kaplan, Eds., Academic Press, New York, 1957, p. 174, incorporated herein by reference). These substrates may be classified in two groups based on the manner in which they create a visually detectable signal. The substrates in the first group react with enzymes to form enzyme-modified products that are themselves chromogenic or fluorescent. The substrates in the second group form enzyme-modified products that must react further with an additional compound to generate a color or fluorescent signal.

Microorganisms that are particularly preferred to serve as the sources of active enzyme in the indicators of the invention include Bacillus stearothermophilus and Bacillus subtilis, which are microorganisms that are commonly used as test microorganisms in spore outgrowth indicators utilized to monitor sterilization procedures. Where dual rapid readout indicators are used, these microorganisms may serve as both the source of active enzyme in the rapid enzyme test and the test microorganism for the spore outgrowth test. Bacillus stearothermophilus is particularly preferred for monitoring both steam and hydrogen peroxide plasma sterilization procedures. Bacillus subtilis is particularly preferred for monitoring ethylene oxide sterilization procedures and may be used to monitor hydrogen peroxide plasma sterilization procedures. 3M™ ATTEST™ 1291 and 1292 Rapid Readout Indicators, commercially available from 3M Company, St. Paul, Minn., are dual rapid readout indicators that measure the activity of the enzyme alpha-D-glucosidase, from Bacillus stearothermophilus, and the growth of B. stearothermophilus live spores.

The sterilant-resistant chemical used in some embodiments of the sterilization indicators of the invention may be any chemical that, when associated with a source of active enzyme, increases the resistance of the enzyme to sterilant so that premature inactivation is avoided. When the source of active enzyme used in the sterilization indicator 10 is the spore of a microorganism, such as Bacillus stearothermophilus or Bacillus subtilis, the spores are preferably treated with the sterilant-resistant chemical before they are placed on the carrier strip 16.

The sterilant-resistant chemical is preferably one that, when associated with the source of active enzyme in the indicator, will prevent the enzyme from being inactivated by a sterilization procedure that is ineffective in that it fails to kill contaminating microorganisms present in the sterilization chamber. Where the sterilization indicator is a dual rapid readout indicator that measures both enzyme activity and spore outgrowth, the sterilant-resistant chemical is preferably one that, when associated with the source of active enzyme, will prevent the enzyme from being inactivated by a sterilization procedure that is not sufficient to kill the test microorganisms used in the indicator for the outgrowth portion of the sterility test.

When a source of active enzyme is treated with the sterilant-resistant chemicals of the invention, the enzyme will preferably have sufficient activity following a sterilization cycle which is sublethal to at least one test microorganism commonly used to monitor sterilization, to react with an effective amount of substrate for the enzyme to produce a detectable enzyme-modified product within less than twenty-four hours; yet the enzyme will have activity which is reduced to background following a sterilization cycle which is lethal to the test microorganism. Most preferably, a source of active enzyme treated with the sterilant-resistant chemicals of the invention, when subjected to a sterilization cycle which would be just sufficient to decrease the population of 1×10⁶ test microorganisms to zero, as measured by lack of outgrowth of the microorganism, has activity equal to background, as measured by reaction with an effective amount of a substrate capable of reacting with the active enzyme to produce a detectable enzyme-modified product; yet when subjected to a sterilization cycle sufficient to decrease the population of 1×10⁶ of the test microorganisms by at least about 1 log but less than about 6 logs, has activity greater than background, as measured by reaction with an effective amount of the substrate.

In a preferred embodiment of the invention the sterilant-resistant chemical is a surfactant having hydrophobic regions and hydrophilic regions on the same molecule and having the general structure R_(a) L_(b), where R represents a hydrophobic group, L represents a hydrophilic group, and a and b are each numbers from 1 to 4. R is preferably an alkyl group of at least 6 carbon atoms, more preferably at least 8 carbon atoms and most preferably at least 12 carbon atoms. L may suitably be selected from the group including carboxyl groups and their salts; hydroxyl groups; sulfonate groups and their salts; sulfate groups and their salts; phosphates; phosphonates; zwitterionic groups; ethylene oxide/propylene oxide copolymer groups; esters or ethers of sorbitan or a polyalkoxylated sorbitan group; polyalkoxylated fatty acid esters or ethers; betaines; amide groups having the structure —NHC(O)R′″ or —C(O)NHR′″, where R′″ is hydrogen or an alkyl group of 1–10 carbon atoms optionally substituted in available positions by N,O, and S atoms; ester groups of short chain alcohols or acids; ether groups; polyglycerol esters or ether groups having 1–20 glycerol units, preferably 2–12 glycerol units and more preferably 3–10 glycerol units; secondary amine groups; and tertiary amine groups.

In a preferred embodiment of the invention the sterilant-resistant chemical may include a surfactant and a hydrophobic additive. The hydrophobic additives are defined as being non-water soluble and non-self dispersible in water, and as such require emulsification by a surfactant. Suitable hydrophobic additives include compounds that are waxes and oils at room temperature. Hydrophobic additives that are appropriate for use as part of the sterilant-resistant chemical include short chain alkyl or aryl esters (C1–C6) of long chain (straight or branched) alkyl or alkenyl alcohols or acids (C8–C36) and their polyethoxylated derivatives; short chain alkyl or aryl esters (C1–C6) of C4–C12 diacids or diols, optionally substituted in available positions by —OH; alkyl or aryl C1–C9 esters of glycerol, pentaerythritol, ethylene glycol; C12–C22 alkyl esters or ethers of polypropylene glycol; C12–C22 alkyl esters or ethers of polypropylene glycol/polyethylene glycol copolymer; poly ether polysiloxane copolymers; cyclic dmethicones; polydialkylsiloxanes; polyaryl/alkylsiloxanes; long chain (C8–C36) alkyl and alkenyl esters of long straight or branched chain alkyl or alkenyl alcohols or acids; long chain (C8–C36) alkyl or alkenyl amides of long straight or branched chain (C8–C36) alkyl or alkenyl amines or acids; hydrocarbons including straight and branched chain alkanes and alkenes, such as squalene, squalane, polyethylene waxes, lanolin, petrolatum and mineral oil; polysiloxane polyalkylene copolymers; dialkoxy dimethyl polysiloxanes; short chain alkyl or aryl esters (C1–C6) of C12–C22 diacids or diols, optionally substituted in available positions by OH; and C12–C22 alkyl and alkenyl alcohols. Suitable hydrophobic additives include isostearyl alcohol, cetyl alcohol, diisopropyl adipate, squalane, mineral oil, isopropyl myristate, dimethicone, lanolin and petrolatum.

In another preferred embodiment the sterilant-resistant chemical is a polyglycerol alkyl ester or ether, or a mixture of chemicals including a polyglycerol alkyl ester or ether. In another preferred embodiment, the sterilant-resistant chemical is an ethoxylated glycerol ester or ether, or a mixture of chemicals including an ethoxylated glycerol ester or ether. The sterilant-resistant chemical may also include, in a preferred embodiment, decaglycerol, sorbitol or mixtures of chemicals including one of them. In another preferred embodiment, the sterilant-resistant chemical is a mixture of decaglycerol monostearate and sorbitol.

Polyglycerol alkyl esters or ethers that may be used as sterilant-resistant chemicals may be selected from chemicals having the formula:

Polyglyerol Alkyl Esters or Ethers

In this formula, n is 0 to 50; R is either H or an ether or ester group of the formula R′ or

where R′ can be H or a C1 to C50 straight chain or branched alkyl, alkylene, aralkyl or alkenyl group, which can be substituted in available positions by N, O and S. The polyglycerol portion may contain linear, branched or cyclic isomers, and is generally available in a broad range of molecular weights.

Polyglycerol alkyl esters or ethers that are preferred for use as sterilant-resistant chemicals in the invention include decaglyceryl monostearate, hexaglyceryl monostearate, tetraglyceryl monostearate, hexaglyceryl polyricinolate, decaglyceryl monolaurate, tetraglyceryl monooleate, decaglyceryl trioleate, decaglyceryl monooleate, decaglyceryl dipalmitate, hexaglyceryl distearate, decaglyceryl monooleate, decaglyceryl monomyristate, decaglyceryl monoisostearate, decaglyceryl diisostearate, hexaglycerol monolaurate, tetraglyceryl monooleate, and decaglyceryl trioleate.

Ethoxylated glycerol esters or ethers that may be used as sterilant-resistant chemicals may be selected from chemicals having the formula:

Ethoxylated Glycerol Esters or Ether

In this formula, n is 0 to 50; R″ can be a C5 to C50 straight chain or branched alkyl, alkylene, aralkyl or aralkenyl group, which can be substituted in available positions by N, O and S; and R′″ can be H or a C1 to C50 straight chain or branched alkyl, alkylene, aralkyl or alkenyl group, which can be substituted in available positions by N, O and S. Preferably R″ is a linear alkyl group of 6–20 carbons, n is 2 to 10, and R′″ is a linear alkyl group of 6 to 20 carbons.

Ethoxylated glycerol esters or ethers that are particularly preferred for use as sterilant-resistant chemicals include glycereth-7-diisononanoate, and polyoxythethylene (5) glyceryl monostearate.

Sterilization indicators 10 of the invention may be prepared according to the methods described in U.S. Pat. No. 5,252,484 and U.S. Pat. No. 5,073,488. When spores are used as the source of active enzyme in the sterilization indicator 10, the spores are grown on culture plates and then removed and washed by sequential suspension in water and centrifugation. The spores are then suspended in a solution containing the sterilant-resistant chemical and transferred to the carrier strip 16 by pipetting. Although any number of spores may be applied to a carrier strip 16 used in the sterilization indicator 10, in the preferred embodiment of the invention 1×10⁶ spores are transferred to each strip.

A person of ordinary skill in the art will be able to ascertain without undue experimentation the optimal concentrations of the various sterilant-resistant chemicals used in practicing the invention. The invention is therefore not limited to the use of the identified chemicals at any specific concentration or range of concentrations. However, the preferred concentrations of the sterilant-resistant chemicals are as follows:

Sterilant-Resistant Chemical Preferred Range (mg/ml) Decaglyceryl monostearate 10–100 Hexaglyceryl monostearate 5–30 Tetraglyceryl monostearate 5–40 Decaglyceryl monolaurate 50–100 Hexaglyceryl monolaurate 50–100 Tetraglyceryl monooleate 50–100 Decaglyceryl trioleate 50–100 Decaglyceryl monoleate 100 Decaglyceryl dipalmtate 50–100 Hexaglyceryl distearate 25–100 Decaglyceryl monooleate 100 Decaglyceryl monomyristate 100 Decaglyceryl monoisostearate 50–100 Decaglyceryl diisostearate 50–100 Glycereth-7-diisononanoate 20–40  Polyoxyethylene (5) glyceryl monostearate 50–100 Decaglycerol 100 Sorbitol 100

The sterilization indicators of the invention may suitably be used to monitor the effectiveness of any type of sterilization procedure, including sterilization procedures that use steam, hydrogen peroxide vapor phase, hydrogen peroxide plasma, ethylene oxide gas, dry heat, propylene oxide gas, methyl bromide, chlorine dioxide, formaldehyde and peracetic acid (alone or with a vapor phase), and any other gaseous or liquid agents. More preferably, the biological indicator may be used to monitor the effectiveness of any sterilization procedures in which there is a risk that the enzyme will be prematurely inactivated during the sterilization cycle. Sterilization indicators of the invention are most preferably used to monitor the effectiveness of a steam sterilization process utilizing a conditioning phase in which a vacuum is drawn in the chamber before steam is introduced, such as those depicted by the graphs in FIGS. 4 and 5.

In another embodiment of the invention, the sterilization indicator 10 is made specifically for use in monitoring the effectiveness of hydrogen peroxide plasma sterilization procedures, by treating the source of active enzyme with one or more sterilant-resistant chemicals that are especially resistant to premature inactivation during the hydrogen peroxide plasma sterilization procedure. These indicators may be used either alone or as part of a test pack, which includes a tray and a lid in addition to the sterilization indicator. The design of the test pack may be adjusted, as discussed below, to provide the sterilization indicator with a variable amount of additional resistance to the hydrogen peroxide plasma procedure. In one embodiment, the test pack may provide no additional resistance relative to the resistance of the indicator when used alone; and in an alternative embodiment, the test pack may provide the indicator with additional resistance that is equivalent to the additional resistance the indicator would experience if placed within a lumen having a defined cross-sectional area and length.

Such sterilization indicators of the invention may be used to monitor the effectiveness of any of the hydrogen peroxide plasma sterilization procedures known in the art, including, for example, the procedures described in U.S. Pat. No. 4,643,876.

In a preferred embodiment of the invention, the hydrogen peroxide plasma indicator of the invention is either an enzyme indicator or a dual rapid readout indicator, as described above, in which the source of active enzyme has been treated with one or more sterilant-resistant chemicals. Suitable sterilant-resistant chemicals include decaglyceryl decaoleate, decaglycerol pentaoleate, tetraglycerol monooleate, decaglyceryl trioleate, decaglycerol hexaoleate, hexaglycerol dioleate, polyoxyethylene (60) glycerol monostearate, polyoxyethylene (20) sorbitan monostearate and hexaglyn di-stearate.

Suitable sterilant-resistant chemicals may include sorbitan fatty acid esters and polyoxyethylene sorbitan fatty acid esters selected from compounds having the formula:

Sorbitan Fatty Acid Esters and Polyoxyethylene Sorbitan Fatty Acid Esters

In this formula, R₁, R₂ and R₃ can be H or

where R₄ and R₅ are straight or branched chain alkyl or alkenyl hydrocarbon chains of at least four carbon atoms, preferably at least 12 carbon atoms, and most preferably at least 16 carbon atoms; and v is 0–200 and preferably 2–30. A most preferred polyoxyethylene sorbitan fatty acid ester is polyoxyethylene (POE) (20) sorbitan monostearate.

In a preferred embodiment of the invention, the hydrogen peroxide plasma indicator is a dual rapid readout indicator in which the spores of a microorganism serve as both the source of active enzyme for the enzyme activity test, and the test microorganism for the spore outgrowth test. Suitable microorganisms include Bacillus stearothermophilus and Bacillus subtilis. In the most preferred embodiment, Bacillus stearothermophilus spores are used in the indicators.

The spores for use in hydrogen peroxide plasma indicators are treated with sterilant-resistant chemicals using the procedure detailed above. Cultured spores are removed from culture plates and washed by sequential suspension in water followed by centrifugation. A predetermined number of spores, preferably 1×10⁶, are then suspended in a solution containing the sterilant-resistant chemical and transferred to the carrier strip 16. A person of ordinary skill in the art will be able to ascertain without undue experimentation the optimal concentrations of the various sterilant-resistant chemicals used in practicing the invention. Accordingly, the invention is not limited to the use of the identified chemicals at any specific concentration or range of concentrations. However, the preferred concentrations of the sterilant-resistant chemicals for use in hydrogen peroxide plasma sterilization procedures are as follows:

Sterilant-Resistant Chemical Preferred Range (mg/ml) Decaglyceryl Decaoleate  5–25 Decaglycerol Pentaoleate 10–50 Tetraglycerol Monooleate 10–50 Decaglyceryl Trioleate 10–50 Decaglycerol Hexaoleate  5–25 Hexaglycerol Dioleate 10–50 Polyoxyethylene (60) Glycerol Monostearate 10–50 Polyoxyethylene (20) Sorbitan Monostearate 10–50 Hexaglyn Distearate 10–50

Sterilization indicators for use with hydrogen peroxide plasma procedures are preferably prepared according to the methods discussed above and have the configuration of the indicator 10 shown in FIG. 1. However, when the indicator is to be used to monitor hydrogen peroxide plasma procedures, closure member 22 is preferably made of a high-density fiber material, such as TYVEK™ high-density polyethylene fiber material, commercially available from E.I. du Pont de NeMours and Co., Wilmington, Del.

In use, the sterilization indicator 10 is placed in the sterilization chamber and exposed to a hydrogen peroxide plasma sterilization procedure. Sterilant enters the indicator 10 through vent 28 and closure member 22, and contacts the source of active enzyme located on enzyme carrier 16. After the procedure is completed, the indicator 10 is removed from the sterilization chamber and the sides of the outer tube 12 are compressed, breaking the frangible inner tube 18 and releasing the enzyme substrate so that it may contact the source of enzyme on carrier strip 16. The sterilization indicator 10 is then incubated for a period of time sufficient for any active enzyme remaining in the indicator to react with the substrate and form an enzyme-modified product, which provides a detectable indication of the failure of the sterilization procedure. The enzyme-modified product may be detectable as fluorescence, luminescence or a color change. If the sterilization procedure is effective and all active enzyme has been inactivated, then no detectable signal is generated upon incubation.

In a more preferred embodiment of the sterilization indicator 30 for use in a hydrogen peroxide plasma sterilization procedure, shown in FIGS. 6–7, the enzyme carrier 36 is located within outer tube 12 near the closed end of the tube, and a barrier 38 is situated between the carrier strip 36 and the inner tube 18. The barrier is preferably a disc of polypropylene blown microfiber material having a weight of 200 g/sq. meter, commercially available as “THINSULATE™ 200-B brand Thermal Insulation” from 3M Company, St. Paul, Minn.

Any of the sterilization indicators of the invention 10, 30 may be used as part of a test pack. The indicator may be a chemical, biological or enzymatic sterilization indicator or a combination of one or more such indicators. Suitable chemical indictors are described, for example, in U.S. Pat. Nos. 6,488,890; 6,485,979; 6,485,978; 6,346,417; 6,287,518; 6,063,631; 5,916,816; 5,895,627; 5,064,576; and PCT Patent Publications WO 0110473 and WO 0140792. In one embodiment of the invention, shown in FIG. 8, non-challenge test pack 40 of the invention provides no additional resistance to the sterilization procedure above the resistance of the sterilization indicator 10 alone. The non-challenge test pack provides an advantage over the use of the indicator without a test pack in that it securely holds the sterilization indicator in a single position during the sterilization procedure. The non-challenge test pack thus alleviates a problem that occurs when sterilization indicators, which are typically small and prone to roll about, become displaced or misplaced in a load of materials during a sterilization procedure.

The non-challenge sterilization test pack 40 includes a plastic tray 42 for holding a sterilization indicator 10 (though an indicator configured of nesting containers is illustrated in FIG. 8, it is well understood that any other suitable sterilization indicator of an alternative construction or design may also be used) and a plastic lid 50 that is associated with the tray 42 in such a manner that sterilant may freely enter the test pack and contact the sterilization indicator without any resistance other than the resistance provided by the sterilization indicator 10 itself. The plastic tray 42 may have any shape but is preferably rectangular or square. The plastic tray 42 has an elevated rim surface 44 that defines the perimeter of the tray and a recessed trough 46 for holding the sterilization indicator 10 in place during a sterilization procedure. A plurality of spaced–apart grooves 48 a–48 f are recessed into the rim surface 44 along the perimeter of the tray 42 and form a series of channels 52 with the surface of the lid 50. The channels should be large enough in cross-sectional area to conduct sterilant from the exterior of the test pack to the sterilization indicator 10 without creating any significant hindrance to the flow of the sterilant through the channel. In a preferred embodiment, the channels have a cross-sectional area equivalent to about the area of a circle with a diameter of 0.25 inches (0.635 cm), and there are six channels, one at each corner of the tray and one along each side. However, it will be readily apparent to one of skill in the art that both the number of channels and their dimensions may be altered without deviating from the scope of the invention.

Preferably, the lid 50 and the portions of the rim surface 44 that contact the lid 50 form a seal that is substantially impermeable to sterilant. Such a seal may preferably be formed by placing a layer of an adhesive between the surfaces of the lid 50 and the rim surface 44 that are in contact with each other. More preferably, the seal may be formed by heat-sealing the plastic lid 50 to the rim surface 44.

During a sterilization procedure the channels conduct sterilant from the sterilization chamber to the sterilization indicator 10 in the recessed trough 46. The sterilant then enters the indicator 10 and contacts the source of active enzyme, as previously described. The indicator 10 is then removed from the non-challenge test pack 40 and the outer tube 18 is compressed, breaking the inner tube 18 and releasing the substrate so that it may contact the enzyme on carrier strip 16. The indicator 10 is then incubated for a period of time sufficient for the substrate to react with any active enzyme and form a detectable enzyme-modified product. The enzyme-modified product may be detectable as a signal such as fluorescence, luminescence or a color change. The appearance of a detectable enzyme-modified product is an indication that the sterilization procedure has failed, in that it may not have killed contaminating microorganisms present in the sterilization chamber.

Both the tray 42 and the lid 50 of the non-challenge test pack 40 are preferably made of plastic materials that are thermally-resistant and that do not retain residual sterilant following a sterilization procedure. As used herein, the term “thermally resistant” means capable of withstanding the maximum temperature achieved in a particular sterilization procedure without deformation, shrinkage, melting or decomposition. The maximum temperature achieved during a sterilization procedure varies depending on the type of sterilization procedure that is being used. For example, many steam sterilization procedures are carried out at temperatures of 121° C. or higher, whereas hydrogen peroxide plasma sterilization procedures are commonly performed at temperatures of less than 60° C. In selecting the proper thermally-resistant plastic for use in a tray, these temperature differences between the various sterilization procedures must properly be taken into consideration and a plastic should be selected with a glass transition temperature above the maximum temperature of the sterilization procedure in which the indicator will be used.

In a preferred embodiment of the non-challenge test pack, suitable for use in hydrogen peroxide plasma sterilization procedures, the tray is made of polyethylene terephthalate with a glycol additive (PETG). Other examples of suitable thermally-resistant plastics for used in test pack tray 42 include polyvinyl chloride, polyethylene, ultra-high molecular weight polyethylene, polyetheramide, polysulfones, chorotrifluoroethylene, polyvinylfluoride, polytetrafluoroethylene (PTFE), polypropylene, polystyrene, and polyesters.

The lid 50 may be made of the same material as the tray 42. Preferably the lid 20 is made of a plastic material that is translucent or transparent. In the most preferred embodiment, suitable for use in hydrogen peroxide plasma sterilization procedures, the lid 50 is made of a transparent film and is heat sealed to the rim surface 44. An example of a suitable transparent film is a polyester film coated with a blend of polyethylene and ethylene vinylacetate, commercially available as SCOTCHPAK™ Polyester Film from 3M Company, St. Paul, Minn.

FIG. 9 shows an alternative test pack, referred to herein as a lumen-challenge test pack, which provides additional resistance to a sterilization indicator that is equivalent to the resistance the indicator would experience if placed within a lumen having a defined cross-sectional area and length. Lumen-challenge test packs provide an accurate method of determining whether a sterilization procedure would be effective in killing microorganisms that may be located deep within the interior of a tube-like instrument.

The lumen-challenge test pack 60 includes a tray 72 for holding a sterilization indicator 10 (again, though an indicator configured of nesting containers is illustrated in FIG. 8, it is well understood that any other suitable sterilization indicator of an alternative construction or design may also be used) and a lid 68. The tray 72 is made of thermally-resistant plastic and has a substantially planar surface 74 having an edge 62 that defines the perimeter of the tray 72. A trough 64 for holding a sterilization indicator 10 is recessed into the planar surface 74. A groove 66 having a defined length is recessed into the planar surface forming a continuous path that extends through the recessed trough 64 and penetrates the edge 62 at two points 76, 78. The lid 68 forms a seal with the substantially planar surface 74 that is substantially impermeable to sterilant. The seal may be formed by placing a layer of adhesive between the planar surface 74 and the surface of the lid 68 that are in contact with each other, or by heat sealing. The space between the lid 68 and the groove 66 defines a lumen path 70 through which sterilant is conducted from the sterilization chamber to the sterilization indicator 10.

The lumen path 70 has a defined length and cross-sectional area. The dimensions of the lumen path may be selected or adjusted to duplicate the conditions in a lumen having known dimensions. In a preferred embodiment of the test pack, which may preferably be used to test the effectiveness of a hydrogen peroxide plasma sterilization procedure, the lumen path is about approximately twelve inches (30.48 cm) long and has a cross-sectional area that is about the area of a circle having a diameter of 0.25 inches (0.635 cm). However, any lumen length and cross-sectional area may be chosen, and all are considered to be within the scope of the invention. FIG. 10, for example, shows an alternative embodiment of the lumen-challenge test pack 80 in which the lumen path has a different length than the lumen path 70 shown in FIG. 8.

In use the test pack 60 is placed in a sterilization chamber and exposed to a sterilization procedure, during which sterilant travels along the lumen path 76 and contacts the sterilization indicator 10. At the end of the procedure, the sterilization indicator 10 is removed from the test pack and handled as described above with reference to the non-challenge test pack.

The tray 72 and the lid 68 are made of thermally-resistant plastic materials that should be selected in the manner described above with regard to the non-challenge test pack. In a preferred embodiment suitable for use in hydrogen peroxide plasma procedures, the tray 72 is made of polyethylene terephthalate with a glycol additive (PETG) and the lid is made of a transparent film comprising a blend of polyethylene and ethylene vinylacetate, commercially available as SCOTCHPAK™ Polyester Film from 3M Company, St. Paul, Minn. The film 68 may be heat-sealed to the tray 72.

Two alternative embodiments of lumen-type challenge test packs are illustrated in FIGS. 11 and 12. FIG. 11 shows a lumen-challenge test pack 90 having a lumen path 70 of a defined length and cross-sectional area. The lumen path is generally in a “Z”-type configuration. For an indicator designed for a hydrogen peroxide plasma sterilization process, the lumen preferably has a length of about 150 mm and a cross-sectional area of about 5 mm. In a manner analogous to the design shown in FIGS. 9 and 10, the lumen path includes a trough 64 for holding a sterilization indicator 10. In the device shown, the indicator is an enzymatic indicator in the form of a tablet containing a source of active enzyme. Such an indictor is described in U.S. Pat. No. 5,486,459 (Burnham et al.), whose description is incorporated herein by reference. In such an indicator system, the tablet contains at least one and preferably a collection of components of a defined enzyme system. After a sterilization process is performed the indicator is exposed (e.g., by partially or completely removing the lid 68), and a specific mix of indicator reagents is added to the indictor to form a mixture. The mixture is then incubated for a period of time sufficient to allow for product formation from the interaction of the enzymes and the reagents in the enzyme system. The interaction of the enzymes may be indicated as designed for in the indication system, for example, by a visible color change or by radioactivity, electric or fluorometric activity. The design of such systems is known in the art and is described, for example, in U.S. Pat. No. 5,486,459. A steriliant barrier (not shown) may also be placed in the trough 64 over the indicator 10. Such a barrier provides a diffusion restrictive environment, which contributes to the resistance of the device. Changing the size, shape, compression or composition of the sterilant barrier can alter the resistance of the device according to the particular needs for which the device is designed. Generally preferred barriers will be made of an open cell foam material such as those described in U.S. Pat. No. 5,830,683 (Hendricks et al.).

FIG. 12 shows a self-contained lumen-challenge test pack for an enzymatic indictor system. The construction of the indicator 100 is similar to that illustrated in FIG. 11. Like the device of FIG. 11, it is shown containing a tablet-type enzymatic indicator 10 disposed within a trough 64 inside the lumen path 70, but the tray 72 also includes a second trough 92 which is in fluid communication with the trough 64 containing the indicator tablet 10. As in the device shown in FIG. 11, a sterilant barrier may also be placed in the trough 64 over the indicator 10. The second trough 92 contains a sealed reservoir filled with the indicator reagent mixture described above. The sealed reservoir may be in the form, for example, of a foil bubble-type package. After sterilization and the attendant exposure of the indicator tablet 10 to a sterilant, the bubble type package may be unsealed by finger pressure to release the reagent mixture into the trough containing the indicator tablet and thereby allow for a reading to be obtained (e.g, by a color change indication reaction) without the need for removal of the lid 68.

FIG. 13 illustrates another challenge-type test pack. The test pack 110 comprises a lumen 94 which is in fluid communication with a chamber 96 containing a enzymatic indicator tablet 10 such as is described above. It is generally considered preferred that the test pack be made of in the form of a semi-rigid foil pouch. The lumen 94 may include a hollow tube of predetermined length and cross-sectional area made of any suitable rigid material that is inserted into the end of the foil body or the lumen may be made as an integral portion of the pouch construction. A second, initially sealed chamber 92 contains the indicator reagent mixture and is in fluid communication with chamber 96. The chamber is conveniently constructed as a bubble portion of the foil test pack, and like the device illustrated in FIG. 12, after a sterilization cycle is complete the bubble may be broken and the contents contacted with the indictor tablet 10. If the indicator system is of a type that uses a color change as an indication that the source of active enzymes was exposed to a predetermined level of sterilant, the chamber 96 may include a clear window 96 that allows for a user to view the color change without the necessity of opening the indictor.

In another embodiment of the invention, a challenge-type sterilization test pack may be constructed of a substantially flat or planar tray having a well in which a sterilization indicator (e.g., a tablet enzymatic indicator as described above) and a sterilant barrier (e.g., a compressible foam) are placed. The tray containing the indicator and the sterilant barrier may be sealed with a lid comprising a material which is penetrable by the sterilant, such as a Tyvek™ medical packaging material available from E.I. duPont de Nemours and Company of Wilmington, Del. In such a device, the challenge function is accomplished through a combination of the resistance provided by the lid material and the sterilant barrier, which effects can be varied according to the needs of the particular application for which the test pack is intended.

The operation of the present invention will be further described with regard to the following detailed examples. These examples are offered to further illustrate the various specific and preferred embodiments and techniques. It should be understood, however, that many variations and modifications may be made while remaining within the scope of the present invention.

EXAMPLES

Examples 1–5 report the results of tests to determine whether sterilization indicators prepared with spores that have been treated with the chemicals listed in Tables 1–5 demonstrate increased resistance to premature inactivation of enzyme in prevacuum steam sterilization cycles. Examples 6–9 report the results of tests to determine whether sterilization indicators prepared with spores that have been treated with the chemicals listed in Tables 6–9 demonstrate increased resistance to premature inactivation of enzyme in hydrogen peroxide plasma sterilization procedures. Example 10 reports the results of tests that demonstrate the effectiveness of the non-challenge test pack and the lumen-challenge test pack of the invention.

Preparation of Indicators

Sterilization indicators for Examples 1–5 were constructed as illustrated in FIGS. 1 and 2, according to the methods set forth in U.S. Pat. No. 5,252,484. The indicators prepared for the Examples were dual rapid readout indicators that provided both a rapid, enzyme-based efficacy test and a confirmatory spore outgrowth test. Spores coated on the carrier strip 16 served as the source of active enzyme whose activity was measured by the rapid enzyme test. These same spores were then incubated in the spore outgrowth portion of the test.

Bacillus stearothermophilus, commercially available as ATCC 7953 from American Type Culture Collection, Rockville, Md., was grown overnight (16 hours) at 58° C. in tryptic soy broth. This culture was used to inoculate the surface of agar plates consisting of 8 g/l nutrient broth, 4 g/l yeast extract, 0.1 g/l manganese chloride and 20 g/l agar at pH 7.2. Plates were incubated at 58° C. for 72 hours. Spores were scraped from the plates and suspended in sterile distilled water. The spores were separated from the vegetative debris by centrifuging the suspension at 7000 rpm and 4° C. for 20 minutes. The supernatant was poured off and the spores were resuspended in sterile distilled water. The cleaning procedure was repeated several times. After the final wash, the spores were suspended in sterile distilled water, at a concentration of approximately 1×10⁸ spores per milliliter.

The spores were then treated with the chemicals identified in Tables 1–5. All chemicals tested were obtained from commercial sources. The spores were centrifuged at 6000 rpm for 10 minutes. The supernatant was removed and mixed with coating chemicals at the concentrations indicated in the tables. The supernatant and coating chemical mixtures were heated at 60–80° C. for several minutes and vortexed to get the material into solution. The spores were then mixed into the sterilant-resistant chemical solution. The sterilant-resistant chemical solution was applied to 5×25 mm, 591 A paper strips (Schleicher & Schuell, Inc., Keene, N.H.) by pipetting 10–15 microliters to each strip for a final population of about 1×10⁶ spores per strip. The strips were dried 16 hours at 37° C.

The treated spore strips were placed on the bottom of the outer container 12 of the indicator 10 and a barrier was inserted between the spore strip 16 and the inner container 18, which contained enzyme substrate. A 1.75 mm ( 11/16 inch) disc of polypropylene blown microfiber material, with a weight of 200 g/m², commercially available as “THINSULATE™ 200-B brand Thermal Insulation” from 3M Company, St. Paul, Minn., was used as the barrier. The inner container 18 contained 0.67 ml nutrient medium, consisting of 17 g of a bacteriological peptone and a 0.17 g/l of L-alanine, as well as 0.1 g 4-methylumbelliferyl-alpha-D-glucoside, commercially available from Sigma Chemical Company, St. Louis, Mo., dissolved in 200 microliters of N,N-dimethylformamide, and 0.03 g bromocresol purple pH indicator dye, per liter of water. The pH of the enzyme substrate and nutrient medium solution was adjusted to 7.6 with 0.1N sodium hydroxide.

The outer vial 12 and the cap 26 are both made of polypropylene. The outer vial 12 was 5.08 cm (2.0 inches) long, with an outer diameter of 85.1 mm (0.335 inches) and an internal diameter of 77.0 mm (0.303 inches). The cap 26 was 1.275 cm (0.510 inches) long with an internal diameter of 83.3 mm (0.328 inches). The inner container 18 was made of glass and was 3.96 cm (1.56 inches) long, with an outer diameter of 65.5 mm (0.258 inches) and a wall thickness of 2.5 mm (0.010 inches). The closure member 22 was a 1.27 mm (0.5 inches) in diameter piece of sterilization grade filter paper.

Sterilization indicators for Examples 6–9 were prepared as described above with the exception that closure member 22 of the sterilization indicator was constructed of TYVEK™ high-density polyethylene fiber material, commercially available from E.I. du Pont de Nemours and Co., Wilmington, Del.

Example 1

This example provides that sterilization indicators made with spores that have been treated with the chemicals in Table 1 demonstrate improved accuracy when compared to indicators made with untreated spores. The chemicals in Table 1 are polyglycerol alkyl esters or ethoxylated glycerol esters.

Sterilization indicators were made as described above with each of the chemicals and concentrations described in Table 1. Control indicators were made using untreated spores. The indicators were placed in metal instrument trays and exposed at 121° C. in a Getinge Steam Sterilizer (Getinge International, Inc., 1100 Towbin Ave., Lakewood, N.J.) using a 4-pulse prevacuum cycle at 121° C. with a vacuum level of 0.075–0.085 bar and a steam pulse to 1.00 bar for each pulse. Indicators were exposed in the sterilizer for between 7 and 13 minutes. This cycle is depicted in the time-pressure diagram in FIG. 5. After exposure the inner containers containing the enzyme substrate and nutrient medium were crushed and the indicators were incubated at 60° C. The indicators were examined for fluorescence using a 3M™ ATTEST™ Model 190 Rapid Autoreader, commercially available from 3M Company, St. Paul, Minn. Additionally, spore growth, as indicated by a color change from purple to yellow, was determined visually after 168 hours of incubation at 60° C.

The chemicals tested were obtained from commercial sources. Decaglycerol monostearate, hexaglyceryl monostearate and tetraglyceryl monostearate were obtained from Nikko Chemicals Co., Tokyo, Japan. Glycereth-7-diisononanoate was obtained from Alzo Co. of Matawan, N.J.

The number of growth positive indicators detected after 168 hours of incubation is recorded in Table 1. The percentages of these growth positive indicators that also demonstrated fluorescence at 1 hr, 2 hr, 3 hr, 4 hr, 5 hr and 6 hr are also recorded in Table 1. For purposes of judging the accuracy of the sterilization indicators in Table 1, a fluorescent positive percentage of 100% is perfect, indicating that all the growth positives were detected as fluorescent positives and no false negatives were detected. A fluorescent positive number of less than 100%, on the other hand, indicates that there were one or more false negatives, in that some of the indicators that were negative for fluorescence were later detected as positive for spore growth.

TABLE 1 NO. GROWTH FLUORESCENCE - COATING CONCENTRATION TOTAL POSITIVE PERCENT POSITIVE CHEMICAL mg/ml. TESTED¹ 168 HR 1 HR 2 HR 3 HR 4 HR 5 HR 6 HR Untreated Control — 113 44 0 9.1 38.6 61.4 70.5 79.5 Decaglyceryl 10 96 39 0 41.0 74.4 82.1 87.2 89.7 Monostearate Decaglyceryl 20 96 34 0 17.6 73.5 91.2 100 100 Monostearate Decaglyceryl 40 114 59 0 69.5 91.5 100 100 100 Monostearate Decaglyceryl 80 96 55 0 85.5 96.4 100 100 100 Monostearate Decaglyceryl 100 72 34 8.8 85.3 100 100 100 100 Monostearate Hexaglyceryl 5 112 50 0 32.0 78.0 84.0 90.0 94.0 Monostearate Hexaglyceryl 10 96 44 0 31.8 63.6 79.5 84.1 86.4 Monostearate Hexaglyceryl 20 96 44 0 61.4 86.4 95.5 97.7 97.7 Monostearate Tetraglyceryl 5 72 37 0 43.2 67.6 83.8 94.6 97.3 Monostearate Tetraglyceryl 10 54 54 0 63.0 81.5 94.4 96.3 98.1 Monostearate Tetraglyceryl 20 96 70 0 74.3 92.9 100.0 100.0 100.0 Monostearate Tetraglyceryl 40 24 19 0 94.7 100.0 100.0 100.0 100.0 Monostearate Glycereth-7- 20 24 6 0 0 66.7 83.3 83.3 83.3 diisononanoate Glycereth-7- 40 42 17 0 64.7 88.2 88.2 94.1 100.0 diisononanoate ¹Total number of indicators exposed to the sterilization procedure regardless of the period of time of the exposure.

Example 2

This example provides evidence of the effect that treating spores with polyglycerol compounds without alkyl esters or ethers has on the accuracy of sterilization indicators made with the treated spores when compared to indicators made with untreated spores.

Sterilization indicators were made as described above with each of the chemicals and concentrations described in Table 2. Control indicators were made using untreated spores. The indicators were placed in metal instrument trays and exposed at 121° C. in a Getinge Steam Sterilizer (Getinge International, Inc., 1100 Towbin Ave., Lakewood, N.J.) using a 4-pulse prevacuum cycle at 121° C. with a vacuum level of 0.075–0.085 bar and a steam pulse to 1.00 bar for each pulse. Indicators were exposed in the sterilizer for between 7 and 13 minutes. This cycle is depicted in the time-pressure diagram in FIG. 5. After exposure the inner containers containing the enzyme substrate and nutrient medium were crushed and the indicators were incubated at 60° C. The indicators were examined for fluorescence using a 3M™ ATTEST™ Model 190 Rapid Autoreader, commercially available from 3M Company, St. Paul, Minn. Additionally, spore growth, as indicated by a color change from purple to yellow, was determined visually after 168 hours of incubation at 60° C.

The number of growth positive indicators detected after 168 hours of incubation is recorded in Table 2. The percentages of these growth positive indicators that demonstrated fluorescence at 1 hr, 2 hr, 3 hr, 4 hr, 5 hr and 6 hr are also recorded in Table 2. For purposes of judging the accuracy of the sterilization indicators in Table 2, a fluorescent positive percentage of 100% is perfect, indicating that all the growth positives were detected. A fluorescent positive number of less than 100%, on the other hand, indicates that there were one or more false negatives, in that some of the indicators that were negative for fluorescence were later detected as positive for spore growth.

When used as spore coatings, hexaglycerol and triglycerol did not improve the accuracy of sterility indicators.

The chemicals tested were obtained from commercial sources. Decaglycerol, hexaglycerol and triglycerol were obtained from Lonza, Inc., Fairlawn, N.J.

TABLE 2 NO. GROWTH FLUORESCENCE - COATING CONCENTRATION TOTAL POSITIVE PERCENT POSITIVE CHEMICAL mg/ml. TESTED² 168 HR 1 HR 2 HR 3 HR 4 HR 5 HR 6 HR Untreated Control — 113 44 0 9.1 38.6 61.4 70.5 79.5 Decaglycerol 5 48 13 0 0 0 23.1 23.1 30.8 Decaglycerol 10 46 13 0 0 7.7 23.1 23.1 30.8 Decaglycerol 20 47 11 0 0 9.1 18.2 45.5 63.6 Decaglycerol 40 48 26 0 0 7.7 42.3 46.2 53.8 Decaglycerol 80 48 25 0 12.0 36.0 64.0 72.0 76.0 Decaglycerol 100 48 29 0 6.9 48.3 69.0 79.3 89.7 Hexaglycerol 5 46 11 0 0 0 9.1 45.5 63.6 Hexaglycerol 10 48 20 0 0 5.0 15.0 35.0 50.0 Hexaglycerol 20 48 18 0 0 11.1 38.9 50.0 61.1 Hexaglycerol 40 45 26 0 0 26.9 46.2 53.8 61.5 Hexaglycerol 80 48 24 0 0 37.5 58.3 70.8 70.8 Triglycerol 5 46 10 0 0 0 10.0 30.0 40.0 Triglycerol 10 47 15 0 6.7 20.0 26.7 53.3 60.0 Triglycerol 20 48 24 0 0 8.3 29.2 41.7 45.8 Triglycerol 40 48 27 0 0 29.6 48.1 51.9 63.0 Triglycerol 80 48 31 0 3.2 38.7 51.6 58.1 64.5 ²Total number of indicators exposed to the sterilization procedure regardless of the period of time of the exposure.

Example 3

This example provides evidence that sterilization indicators made with spores that have been treated with a mixture of decaglyceryl monostearate and sorbitol, or with decaglycerol monostearate alone, demonstrate improved accuracy when compared with sterility indicators made with untreated spores or spores treated with sorbitol alone.

Sterilization indicators were made as described above with each of the chemicals and concentrations described in Table 3. Control indicators were made using untreated spores. The indicators were placed in metal instrument trays and exposed at 121° C. in a Getinge Steam Sterilizer (Getinge International, Inc., 1100 Towbin Ave., Lakewood, N.J.) using a 4-pulse prevacuum cycle at 121° C. with a vacuum level of 0.075–0.085 bar and a steam pulse to 1.00 bar for each pulse. Indicators were exposed in the sterilizer for between 7 and 15 minutes. This cycle is depicted in the time-pressure diagram in FIG. 5. After exposure the inner containers containing the enzyme substrate and nutrient medium were crushed and the indicators were incubated at 60° C. The indicators were examined for fluorescence using a 3M™ ATTEST™ Model 190 Rapid Autoreader, commercially available from 3M Company, St. Paul, Minn. Additionally, spore growth, as indicated by a color change from purple to yellow, was determined visually after 168 hours of incubation at 60° C.

The number of growth positive indicators detected after 168 hours of incubation is recorded in Table 3. The percentages of these growth positive indicators that demonstrated fluorescence at 1 hr, 2 hr, 3 hr and 4 hr are recorded in Table 3. For purposes of judging the accuracy of the sterilization indicators in Table 2, a fluorescent positive percentage of 100% is perfect, indicating that all the growth positives were detected. A fluorescent positive number of less than 100%, on the other hand, indicates that there were one or more false negatives, in that some of the indicators that were negative for fluorescence were later detected as positive for spore growth.

The chemicals tested were obtained from commercial sources. Sorbitol was obtained from Paddock Laboratories, Minneapolis, Minn. Decaglyceryl monostearate was obtained from Nikko Chemicals, Co., Tokyo, Japan.

TABLE 3 GROWTH FLUORESCENCE - COATING CONCENTRATION TOTAL POSITIVE PERCENT POSITIVE CHEMICAL mg/ml. TESTED³ 168 HR 1 HR 2 HR 3 HR 4 HR Uncoated Control — 48 20 0 15.0 55.0 85.0 Sorbitol 100 48 36 0 52.8 83.3 91.7 Decaglycerol 100 48 20 0 100.0 100.0 100.0 Monostearate Mixture of 48 27 40.7 100.0 100.0 100.0 a) Decaglycerol a) 100 Monostearate and b) Sorbitol b) 100 ³Total number of indicators exposed to the sterilization procedure regardless of the period of time of the exposure.

Example 4

This example provides evidence that some of the chemicals in Table 4, when used to treat spores used in sterilization indicators, improve the accuracy of the indicators when compared to indicators made with untreated spores.

Sterilization indicators were made as described above with each of the chemicals and concentrations described in Table 4. Control indicators were made using untreated spores. The indicators were placed in metal instrument trays and exposed at 121° C. in a Getinge Steam Sterilizer (Getinge International, Inc., 1100 Towbin Ave., Lakewood, N.J.) using a 4-pulse prevacuum cycle at 121° C. with a vacuum level of 0.075–0.085 bar and a steam pulse to 1.00 bar for each pulse. Indicators were exposed in the sterilizer for between 7 and 18 minutes. This cycle is depicted in the time-pressure diagram in FIG. 5. After exposure the inner containers containing the enzyme substrate and nutrient medium were crushed and the indicators were incubated at 60° C. The indicators were examined for fluorescence using a 3M™ ATTEST™ Model 190 Rapid Autoreader, commercially available from 3M Company, St. Paul, Minn. Additionally, spore growth, as indicated by a color change from purple to yellow, was determined visually after 168 hours of incubation at 60° C.

The number of growth positive indicators detected after 168 hours of incubation is recorded in Table 4. The percentages of these growth positive indicators that demonstrated fluorescence at 1 hr, 2 hr, 3 hr and 4 hr are recorded in Table 4. For purposes of judging the accuracy of the sterilization indicators in Table 4, a fluorescent positive percentage of 100% is perfect, indicating that all the growth positives were detected. A fluorescent positive number of less than 100%, on the other hand, indicates that there were one or more false negatives, in that some of the indicators that were negative for fluorescence were later detected as positive for spore growth.

The accuracy of sterilization indicators was improved when spores used in the indicators were treated with decaglyceryl monostearate, decaglyceryl monolaurate, hexaglyceryl monolaurate, tetraglyceryl monooleate, decaglyceryl monooleate, decaglycerol dipalmitate and hexaglyceryl distearate. This effect was increased when the spores were treated with the chemicals at higher concentrations.

The chemicals tested were obtained from commercial sources. Decaglycerol monostearate, hexaglyceryl polyricinolate, hexaglyceryl pentaoleate, decaglyceryl monolaurate, hexaglyceryl monolaurate, tetraglyceryl monooleate, and decaglyceryl trioleate were obtained from Nikko Chemicals Co., Tokyo, Japan. Decaglyceryl monooleate, decaglyceryl dipalmitate, hexaglyceryl dioleate, decaglyceryl hexaoleate, hexaglyceryl distearate and decaglyceryl decaoleate were obtained from Lonza, Inc., Fairlawn, N.J.

TABLE 4 NO. GROWTH FLUORESCENCE - COATING CONCENTRATION TOTAL POSITIVE PERCENT POSITIVE CHEMICAL mg/ml. TESTED⁴ 168 HR 1 HR 2 HR 3 HR 4 HR Untreated Control — 42 29 20.7 31.0 44.8 58.6 Untreated Control — 42 30 0 26.7 43.3 66.7 Sorbitol 100 42 37 5.4 40.5 81.1 89.2 Decaglyceryl 50 42 29 13.8 86.2 100.0 100.0 Monostearate Hexaglyceryl 50 42 23 0 13.0 52.2 56.5 Polyricinolate Hexaglyceryl 100 45 31 9.7 19.4 32.3 45.2 Polyricinolate Decaglyceryl 50 42 16 0 0 18.8 31.3 Pentaoleate Decaglyceryl 100 47 24 12.5 25.0 37.5 45.8 Pentaoleate Decaglyceryl 50 42 11 0 27.3 72.7 72.7 Monolaurate Decaglyceryl 100 45 23 87 100.0 100.0 100.0 Monolaurate Hexaglyceryl 50 42 7 0 28.6 57.1 71.4 Monolaurate Hexaglyceryl 100 43 20 90.0 100.0 100.0 100.0 Monolaurate Tetraglyceryl 50 42 17 0.0 52.9 52.9 58.8 Monooleate Tetraglyceryl 100 47 35 57.1 100.0 100.0 100.0 Monooleate Decaglyceryl 50 42 19 0.0 21.1 47.4 68.4 Trioleate Decaglyceryl 100 47 26 23.1 50.0 73.1 92.3 Trioleate Decaglyceryl 50 42 10 0 0 0 0 Monooleate Decaglyceryl 100 47 26 7.7 23.1 50 73.1 Monooleate Decaglyceryl 50 42 28 7.1 67.9 89.3 92.9 Dipalmitate Decaglyceryl 100 33 26 34.6 61.5 69.2 69.2 Dipalmitate Hexaglyceryl 50 42 7 0 0 0 0 Dioleate Hexaglyceryl 100 47 23 0 0 0 0 Dioleate Decaglyceral 50 42 9 0 0 22.2 55.6 Hexaoleate Decaglyceral 100 47 18 5.6 16.7 27.8 33.3 Hexaoleate Hexaglyceryl 25 30 29 27.6 51.7 58.6 62.1 Distearate Hexaglyceryl 50 33 33 30.3 57.6 97 100 Distearate Hexaglyceryl 100 21 21 71.4 100 100 100 Distearate Decaglyceryl 50 42 31 0 19.4 29.0 41.9 Decaoleate Decaglyceryl 100 46 30 16.7 20 30 50 Decaoleate ⁴Total number of indicators exposed to the sterilization procedure regardless of the period of time of the exposure.

Example 5

This example provides evidence that some of the chemicals in Table 5, when used to treat spores used in sterilization indicators, improved the accuracy of the indicators when compared to indicators made with untreated spores.

Sterilization indicators were made as described above with each of the chemicals and concentrations described in Table 5. Control indicators were made using untreated spores. The indicators were placed in metal instrument trays and exposed at 121° C. in a Getinge Steam Sterilizer (Getinge International, Inc., 1100 Towbin Ave., Lakewood, N.J.) using a 4-pulse prevacuum cycle at 121° C. with a vacuum level of 0.075–0.085 bar and a steam pulse to 1.00 bar for each pulse. Indicators were exposed in the sterilizer for between 7 and 13 minutes. This cycle is depicted in the time-pressure diagram in FIG. 5. After exposure the inner containers containing the enzyme substrate and nutrient medium were crushed and the indicators were incubated at 60° C. The indicators were examined for fluorescence using a 3M™ ATTEST™ Model 190 Rapid Autoreader, commercially available from 3M Company, St. Paul, Minn. Additionally, spore growth, as indicated by a color change from purple to yellow, was determined visually after 168 hours of incubation at 60° C.

The number of growth positive indicators detected after 168 hours of incubation is recorded in Table 5. The percentages of these growth positive indicators that demonstrated fluorescence at 1 hr, 2 hr, 3 hr and 4 hr are also recorded in Table 5. For purposes of judging the accuracy of the sterilization indicators in Table 5, a fluorescent positive percentage of 100% is perfect, indicating that all the growth positives were detected. A fluorescent positive number of less than 100%, on the other hand, indicates that there were one or more false negatives, in that some of the indicators that were negative for fluorescence were later detected as positive for spore growth.

The accuracy of sterilization indicators was improved when spores used in the indicators were treated with polyoxyethylene (5) glyceryl monostearate, decaglyceryl monooleate, and decaglyceryl monomyristate, decaglyceryl monoisostearate and decaglyceryl diisostearate. This effect was increased when the spores were treated with the chemicals at higher concentrations.

All chemicals were obtained from Nikko Chemicals Co., Tokyo, Japan.

TABLE 5 NO. GROWTH FLUORESCENCE - COATING CONCENTRATION TOTAL POSITIVE PERCENT POSITIVE CHEMICAL mg/ml. TESTED⁵ 168 HR 1 HR 2 HR 3 HR 4 HR Control — 9 7 28.6 42.9 42.9 42.9 POE⁶ (5) Glyceryl 50 25 15 0 100.0 100.0 100.0 Monostearate POE (5) Glyceryl 100 12 5 0 100 100 100 Monostearate POE(60) Sorbitol 50 9 5 0 0 0 0 Tetrastearate POE(15) Glyceryl 50 15 7 0 0 42.9 57.1 Monostearate POE(15) Glyceryl 100 15 4 0 0 0 0 Monostearate POE(10) 50 9 2 0 0 0 0 Phytosterol Decaglyceryl 50 27 6 0 0 0 0 Monooleate Decaglyceryl 100 27 2 0 50 100 100 Monooleate Sodium POE(8) 50 9 6 0 0 0 0 Oleyl Ether Phosphate Sodium POE(8) 100 9 3 0 0 0 0 Oleyl Ether Phosphate POE(20) Sorbitan 50 9 5 0 0 0 0 Monostearate POE(20) Sorbitan 100 9 2 0 0 0 0 Monostearate Decaglyceryl 50 9 3 0 33.3 33.3 33.3 Monomyristate Decaglyceryl 100 9 2 0 100 100 100 Monomyristrate Decaglyceryl 50 19 9 33.3 77.8 88.9 88.9 Monoisostearate Decaglyceryl 100 15 8 37.5 100 100 100 Monoisostearate Decaglyceryl 50 14 10 30 80.0 100 100 Diisostearate Decaglyceryl 100 22 14 28.6 100.0 100 100 Diisostearate POE(15) Glyceryl 50 9 1 0 0 0 0 Monooleate POE(5) Glyceryl 50 9 2 0 0 0 0 Monooleate POE(5) Glyceryl 100 9 2 0 0 0 0 Monooleate POE(60) Sorbitol 50 9 2 0 0 0 0 Tetraoleate POE(60) Sorbitol 100 9 2 0 0 0 0 Tetraoleate ⁵Total tested is the total number of indicators exposed to the sterilization procedure regardless of the period of time of the exposure. ⁶Polyoxyethylene

Example 6

This Example reports the results of an experiment to determine whether enzymes associated with spores that have been treated with the chemicals listed in Table 6 are more resistant to premature inactivation in hydrogen peroxide plasma sterilization procedures than enzymes associated with untreated spores.

Sterilization indicators were made as described above with spores that had been coated with each of the chemicals and concentrations listed in Table 6. The indicators were placed in instrument trays and exposed to a hydrogen peroxide plasma sterilization procedure at 45–55° C. in a STERRAD™ 100SI GMP Sterilizer, obtained from Advanced Sterilization Products Co., Irvine, Calif. During the sterilization procedure a vacuum was drawn in the sterilization chamber for 5–6 minutes until the pressure was reduced to 300 mTorr. A 1.8 ml aliquot of an aqueous solution of 58–60% hydrogen peroxide was then injected into the sterilization chamber over a period of about 6 minutes, yielding an empty chamber concentration of 6–7 mg/ml hydrogen peroxide, and hydrogen peroxide vapor was allowed to diffuse throughout the chamber for 1–22 minutes at 6–10 Torr. A vacuum was then drawn, reducing the pressure to 500 mTorr and removing all detectable hydrogen peroxide vapor from the chamber. A plasma phase was then generated in the chamber by emitting an RF power source at 400 watts and 13.56 MHz for about 15–16 minutes at 500 mTorr, after which the chamber was vented for 3–4 minutes until atmospheric pressure was reached in the chamber.

After exposure to the sterilization procedure, the indicators were removed from the sterilizer and the inner containers containing the enzyme substrate and nutrient medium were crushed. The indicators were then incubated at 60° C. and examined for fluorescence every hour for 5 hours using a 3M™ ATTEST™ Model 190 Rapid Autoreader, commercially available from 3M Company, St. Paul, Minn. Additionally, spore growth, as indicated by a color change from purple to yellow, was determined visually after 168 hours of incubation.

The number of growth positive indicators detected after 168 hours of incubation is recorded in Table 6. The percentages of these growth positive indicators that demonstrated fluorescence at 1 hr, 2 hr, 3 hr, 4 hr and 5 hr are also recorded in Table 6. For purposes of judging the accuracy of the sterilization indicators in Table 6, a fluorescent positive percentage of 100% is perfect, indicating that all growth positives were detected. A fluorescent positive number of less than 100%, on the other hand, indicates that there were one or more false negatives, in that some of the indicators that were negative for fluorescence were later detected as positive for spore growth.

The data in Table 6 indicates that the accuracy of the sterilization indicators is improved in hydrogen peroxide plasma sterilization procedures, 1–3 hours after exposure, compared to indicators made with untreated spores, when the indicators are prepared with spores that have been treated with decaglyceryl decaoleate, decaglycerol pentaoleate, tetraglycerol monooleate, decaglycerol hexaoleate, and 1,2,3-Propantrial. It can be inferred from the data that treatment with these chemicals increases the resistance of the enzyme to premature inactivation in hydrogen peroxide plasma sterilization procedures.

All chemicals listed in Table 6 were obtained from commercial sources. Decaglyceryl decaoleate, decaglycerol hexaoleate, hexaglycerol dioleate and decaglycerol pentaoleate were obtained from Lonza, Inc., Fairlawn, N.J. Tetraglycerol monooleate and decaglycerol trioleate were obtained from Nikko Chemicals Co., Tokyo, Japan.

TABLE 6 NO. GROWTH CONCENTRATION TOTAL POSITIVE FLUORESCENCE - PERCENT POSITIVE COATING CHEMICAL mg/ml TESTED⁷ 168 HR. 1 HR. 2 HR. 3 HR. 4 HR. 5 HR Untreated Control — 110 75 73.3 84.0 94.7 100 100 Decaglyceryl Decaoleate 10 100 49 83.7 100 100 100 100 Decaglycerol Pentaoleate 50 30 17 82.4 94.1 100 100 100 Tetraglycerol Monooleate 50 14 11 76.6 90.9 100 100 100 Decaglycerol Trioleate 50 53 40 85.0 97.5 100 100 100 Decaglycerol Hexaoleate 10 25 12 100 100 100 100 100 Hexaglycerol Dioleate 50 12 6 66.7 100 100 100 100 ⁷Total Tested = Total number of indicators exposed to the sterilization procedure.

Example 7

This Example reports the results of an experiment to determine whether enzymes associated with spores that have been treated with the chemicals listed in Table 7 are more resistant to premature inactivation in hydrogen peroxide plasma sterilization procedures than enzymes associated with untreated spores.

Sterilization indicators were made as described above with spores that had been coated with each of the chemicals and concentrations listed in Table 7. The indicators were placed in instrument trays and exposed to a hydrogen peroxide plasma sterilization procedure at 45–55° C. in a STERRAD™ 100SI GMP Sterilizer, obtained from Advanced Sterilization Products Co., Irvine, Calif. During the sterilization procedure a vacuum was drawn in the sterilization chamber for 5–6 minutes until the pressure was reduced to 300 mTorr. A 1.8 ml aliquot of an aqueous solution of 58–60% hydrogen peroxide was then injected into the sterilization chamber over a period of about 6 minutes, yielding an empty chamber concentration of 6–7 mg/ml hydrogen peroxide, and hydrogen peroxide vapor was allowed to diffuse throughout the chamber for 1–22 minutes at 6–10 Torr. A vacuum was then drawn, reducing the pressure to 500 mTorr and removing all detectable hydrogen peroxide vapor from the chamber. A plasma phase was then generated in the chamber by emitting an RF power source at 400 watts and 13.56 MHz for about 15–16 minutes at 500 mTorr, after which the chamber was vented for 3–4 minutes until atmospheric pressure was reached in the chamber.

After exposure to the sterilization procedure, the indicators were removed from the sterilizer and the inner containers containing the enzyme substrate and nutrient medium were crushed. The indicators were then incubated at 60° C. and examined for fluorescence every hour for 5 hours using a 3M™ ATTEST™ Model 190 Rapid Autoreader, commercially available from 3M Company, St. Paul, Minn. Additionally, spore growth, as indicated by a color change from purple to yellow, was determined visually after 168 hours of incubation.

The number of growth positive indicators detected after 168 hours of incubation is recorded in Table 7. The percentages of these growth positive indicators that demonstrated fluorescence at 1 hr, 2 hr, 3 hr, 4 hr and 5 hr are also recorded in Table 7. For purposes of judging the accuracy of the sterilization indicators in Table 7, a fluorescence positive percentage of 100% is perfect, indicating that all growth positives were detected. A fluorescent positive number of less than 100%, on the other hand, indicates that there were one or more false negatives, in that some of the indicators that were negative for fluorescence were later detected as positive for spore growth.

The data in Table 7 indicates that the accuracy of sterilization indicators is improved in hydrogen peroxide plasma sterilization procedures, 2–3 hours after exposure, compared to indicators made with untreated spores, when the indicators are prepared with spores that have been treated with decaglyceryl decaoleate, POE (60) glycerol monostearate and POE (20) sorbitan monostearate. It can be inferred from the data that treatment with these chemicals increases the resistance of the enzyme to premature inactivation in hydrogen peroxide plasma sterilization procedures.

All chemicals listed in Table 7 were obtained from commercial sources. Decaglyceryl decaoleate was obtained from Lonza, Inc., Fairlawn, N.J. Decaglyceryl monostearate, hexaglyceryl polyricinolate, POE (60) glycerol monostearate and POE (20) sorbitan monostearate were obtained from Nikko Chemicals Co., Tokyo, Japan.

TABLE 7 NO. GROWTH FLUORESCENCE - PERCENT CONCENTRATION TOTAL POSITIVE POSITIVE COATING CHEMICAL mg/ml TESTED⁸ 168 HR. 1 HR. 2 HR. 3 HR. 4 HR. 5 HR Untreated Control — 110 75 73.3 84.0 94.7 100 100 Decaglyceryl Decaoleate 10 100 49 83.7 100 100 100 100 Decaglycerol Monostearate 50 68 59 64.4 83.0 89.8 91.3 91.3 Hexaglyceryl Polyricinolate 50 20 12 83.3 91.7 91.7 91.7 91.7 POE⁹(60) Glycerol 50 16 7 100 100 100 100 100 Monostearate POE(60) Glycerol 100 16 7 57.1 57.1 71.4 71.4 71.4 Monostearate POE(20) Sorbitan 50 16 6 100 100 100 100 100 Monostearate POE(20) Sorbitan 100 16 8 50 50 62.5 75 75 Monostearate ⁸Total Tested = Total number of indicators exposed to the sterilization procedure. ⁹POE = Polyoxyethylene

Example 8

This Example reports the results of an experiment to determine whether enzymes associated with spores that have been treated with the chemicals listed in Table 8 are more resistant to premature inactivation in hydrogen peroxide plasma sterilization procedures than enzymes associated with untreated spores.

Sterilization indicators were made as described above with spores that had been coated with each of the chemicals and concentrations listed in Table 8. The indicators were placed in instrument trays and exposed to a hydrogen peroxide plasma sterilization procedure at 45–55° C. in a STERRAD™ 100SI GMP Sterilizer, obtained from Advanced Sterilization Products Co., Irvine, Calif. During the sterilization procedure a vacuum was drawn in the sterilization chamber for 5–6 minutes until the pressure was reduced to 300 mTorr. A 1.8 ml aliquot of an aqueous solution of 58–60% hydrogen peroxide was then injected into the sterilization chamber over a period of about 6 minutes, yielding an empty chamber concentration of 6–7 mg/ml hydrogen peroxide, and hydrogen peroxide vapor was allowed to diffuse throughout the chamber for 1–22 minutes at 6–10 Torr. A vacuum was then drawn, reducing the pressure to 500 mTorr and removing all detectable hydrogen peroxide vapor from the chamber. A plasma phase was then generated in the chamber by emitting an RF power source at 400 watts and 13.56 MHz for about 15–16 minutes at 500 mTorr, after which the chamber was vented for 3–4 minutes until atmospheric pressure was reached in the chamber.

After exposure to the sterilization procedure, the indicators were removed from the sterilizer and the inner containers containing the enzyme substrate and nutrient medium were crushed. The indicators were then incubated at 60° C. and examined for fluorescence every hour for 5 hours using a 3m™ ATTEST™ Model 190 Rapid Autoreader, commercially available from 3M Company, St. Paul, Minn. Additionally, spore growth, as indicated by a color change from purple to yellow, was determined visually after 168 hours of incubation.

The number of growth positive indicators detected after 168 hours of incubation is recorded in Table 8. The percentages of these growth positive indicators that demonstrated fluorescence at 1 hr, 2 hr, 3 hr, 4 hr and 5 hr are also recorded in Table 8. For purposes of judging the accuracy of the sterilization indicators in Table 8, a fluorescence positive percentage of 100% is perfect, indicating that all growth positives were detected. A fluorescent positive number of less than 100%, on the other hand, indicates that there were one or more false negatives, in that some of the indicators that were negative for fluorescence were later detected as positive for spore growth.

The data in Table 8 indicates that the accuracy of sterilization indicators is improved in hydrogen peroxide plasma sterilization procedures, 1–3 hours after exposure, compared to indicators made with untreated spores, when the indicators are prepared with spores that have been treated with hexaglyn di-stearate. It can be inferred from the data that treatment with this chemicals increases the resistance of the enzyme to premature inactivation in hydrogen peroxide plasma sterilization procedures.

All chemicals listed in Table 8 were obtained from commercial sources. Alkyl polyglucoside was obtained from Henkel Co., Hoboken, N.J. Hexaglyn di-stearate and decaglycerol dipalmitate were obtained from Lonza, Inc., Fairlawn, N.J. Sodium POE (8) oleyl ether phosphate was obtained from Nikko Chemicals Co., Tokyo, Japan.

TABLE 8 NO. GROWTH FLUORESCENCE - PERCENT CONCENTRATION TOTAL POSITIVE POSITIVE COATING CHEMICAL mg/ml TESTED¹⁰ 168 HR. 1 HR. 2 HR. 3 HR. 4 HR. 5 HR Untreated Control — 16 7 14.3 57.1 85.7 100 100 Alkyl Polyglucoside 20 12 5 0 0 0 0 0 Alkyl Polyglucoside 40 12 1 0 0 0 0 0 Sodium POE¹¹(8) Oleyl 50 16 0 0 0 0 0 0 Ether Phosphate Sodium POE(8) Oleyl Ether 100 16 0 0 0 0 0 0 Phosphate Hexaglyn Di-Stearate 25 16 16 100 100 100 100 100 Hexaglyn Di-Stearate 50 16 16 100 100 100 100 100 Hexaglyn Di-Stearate 100 16 16 100 100 100 100 100 Decaglycerol Dipalmitate 50 28 27 66.7 74.1 77.8 77.8 77.8 ¹⁰Total Tested = Total number of indicators exposed to the sterilization procedure. ¹¹POE = Polyoxyethylene

Example 9

This Example reports the results of an experiment to determine the effective concentration range of decaglyceryl decaoleate for use in treating spores to prevent premature inactivation enzymes associate with the spores in hydrogen peroxide plasma sterilization procedures than enzymes in untreated spores.

Sterilization indicators were made as described above with spores that had been coated with decaglyceryl decaoleate at each of the concentrations listed in Table 9. The indicators were placed in instrument trays and exposed to a hydrogen peroxide plasma sterilization procedure at 45–55° C. in a STERRAD™ 100SI GMP Sterilizer, obtained from Advanced Sterilization Products Co., Irvine, Calif. During the sterilization procedure a vacuum was drawn in the sterilization chamber for 5–6 minutes until the pressure was reduced to 300 mTorr. A 1.8 ml aliquot of an aqueous solution of 58–60% hydrogen peroxide was then injected into the sterilization chamber over a period of about 6 minutes, yielding an empty chamber concentration of 6–7 mg/ml hydrogen peroxide, and hydrogen peroxide vapor was allowed to diffuse throughout the chamber for 1–22 minutes at 6–10 Torr. A vacuum was then drawn, reducing the pressure to 500 mTorr and removing all detectable hydrogen peroxide vapor from the chamber. A plasma phase was then generated in the chamber by emitting an RF power source at 400 watts and 13.56 MHz for about 15–16 minutes at 500 mTorr, after which the chamber was vented for 3–4 minutes until atmospheric pressure was reached in the chamber.

After exposure to the sterilization procedure, the indicators were removed from the sterilizer and the inner containers containing the enzyme substrate and nutrient medium were crushed. The indicators were then incubated at 60° C. and examined for fluorescence every hour for 5 hours using a 3M™ ATTEST™ Model 190 Rapid Autoreader, commercially available from 3M Company, St. Paul, Minn. Additionally, spore growth, as indicated by a color change from purple to yellow, was determined visually after 168 hours of incubation.

The number of growth positive indicators detected after 168 hours of incubation is recorded in Table 9. The percentages of these growth positive indicators that demonstrated fluorescence at 1 hr, 2 hr, 3 hr, 4 hr and 5 hr are also recorded in Table 9. For purposes of judging the accuracy of the sterilization indicators in Table 9, a fluorescence positive percentage of 100% is perfect, indicating that all growth positives were detected. A fluorescent positive number of less than 100%, on the other hand, indicates that there were one or more false negatives, in that some of the indicators that were negative for fluorescence were later detected as positive for spore growth.

The data in Table 9 indicates that the accuracy of sterilization indicators is improved in hydrogen peroxide plasma sterilization procedures, 2–3 hours after exposure, compared to indicators made with untreated spores, when the indicators are prepared with spores that have been treated with decaglyceryl decaoleate at concentrations of 5–100 mg/ml

Decaglyceryl decaoleate was obtained from Lonza, Inc., Fairlawn, N.J.

TABLE 9 NO. GROWTH CONCENTRATION TOTAL POSITIVE FLUORESCENCE - PERCENT POSITIVE COATING CHEMICAL mg/ml TESTED¹² 168 HR. 1 HR. 2 HR. 3 HR. 4 HR. 5 HR Untreated Control — 110 75 73.3 84.0 94.7 100 100 Decaglyceryl Decaoleate 5 65 35 65.7 100 100 100 100 Decaglyceryl Decaoleate 7.5 52 35 83.5 100 100 100 100 Decaglyceryl Decaoleate 10 100 49 83.7 100 100 100 100 Decaglyceryl Decaoleate 50 32 21 85.0 90.2 100 100 100 Decaglyceryl Decaoleate 100 38 30 73.3 86.7 100 100 100 ¹²Total Tested = Total number of indicators exposed to the sterilization procedure.

Example 10

This Example reports the results of an experiment to determine whether the lumen-challenge test pack of the invention increases the resistance of a sterilization indicator within the test pack to a hydrogen peroxide plasma sterilization procedure.

Lumen-challenge test packs made according to the invention were exposed to partial and full cycles of a hydrogen peroxide plasma procedure, along with non-challenge test packs made according to the invention, a laboratory lumen-challenge device, and a sterilization indicator exposed without a test pack. The lumen-challenge test packs and the non-challenge test packs used in the Example included a sterilization indicator prepared as described above, with spores that had been treated with decaglycerol decaoleate at 5 mg/ml. The experimental lumen-challenge device included a carrier strip that was identical to the carrier strip in the sterilization indicators used in the test packs. The results of the experiment are reported in Table 10.

Four types of lumen-challenge test packs were prepared having lumen paths with lengths of 12 inches (30.48 cm), 9 inches (22.86 cm), 6 inches (15.24 cm) and 3 inches (7.62 cm), respectively. Each test pack had a lumen with a cross-sectional area equivalent to the area of a circle having a diameter of 0.25 inches (0.635 cm). The test packs included a test pack tray, a sterilization indicator and a lid.

The test pack trays were made by molding polyethylene terephthalate with a glycol additive (PETG), obtained from Eastman Kodak, Rochester, N.Y., in a Sencorp Model 1600 machine, obtained from Sencorp, Inc., Hyannis, Mass., using a pressure-forming process driven by vacuum and heat. The molds used in making the trays were made in a Fadal cutter machine, available from Fadal Engineering, a subsidiary of Gidding & Lewis, Inc., Chatsworth, Calif. The test pack trays were rectangular in shape and had a substantially planar surface. A recessed groove in the tray extended along a U-shaped path on the tray surface and penetrated the edge of the tray in two places, forming two lumen path openings through which sterilant could enter and leave the test pack during a sterilization procedure. The distance between the lumen path openings was 3.398 inches (8.630 cm). A semi-cylindrical trough having a radius of 0.219 inches (0.55626 cm) and a length of 2.435 inches (6.191 cm) was recessed into the tray at the midpoint of the lumen path, for holding a sterilization indicator in place during the sterilization procedure. The length of the side of the tray that included the lumen path openings, and of the side facing that side, was 4.300 inches (10.922 cm). The length of the other side varied depending on the length of the lumen path, and was 5.700 inches (14.478 cm) for the 12 inch (30.48 cm) lumen path test pack, 4.313 inches (10.955 cm) for the 9 inch (22.86 cm) lumen path test pack, 3.063 inches (7.780 cm) for the 6 inch (15.24 cm) lumen path test pack, and 1.938 inches (4.922 cm) for the 3 inch (7.62 cm) lumen path test pack. A sterilization indicator was placed in the trough of the test pack tray, and the tray was covered with a lid of SCOTCHPAK™ polyester film, 0.85 mils thick, No. 29312, obtained from 3M Company, St. Paul, Minn. The film was heat-sealed to the tray using an ordinary clothes iron.

The non-challenge test pack included a test pack tray, a sterilization indicator and a lid. The test pack tray was made of PETG using the same molding process and machinery used to make the lumen-challenge test pack trays. The tray was rectangular in shape and had two sides with a length of 2.50 inches (6.35 cm) and two sides with a length of 4.20 inches (10.668 cm). An elevated rim with a flat top surface extended 0.50 inches (1.27 cm) inward from each side of the tray. A semi-cylindrical trough having a radius of 0.219 inches (0.55626 cm) and a length of 2.435 inches (6.191 cm) was recessed into the center of the tray for holding a sterilization indicator in place during a sterilization procedure. Grooves having a diameter of 0.25 inches (0.635 cm) were recessed into the elevated rim at each corner and at the midpoint of each side. The grooves extended completely through the elevated rim and formed a channel to carry sterilant to the sterilization indicator in the recessed trough during a sterilization procedure. A sterilization indicator was placed in the trough of the tray, and the tray was covered with a lid of SCOTCHPAK™ polyester film, 0.85 mils thick, No. 29312, obtained from 3M Company, St. Paul, Minn. The film was heat-sealed to the tray using an ordinary clothes iron.

The laboratory lumen-challenge device used in the Example was 30 cm long and included a stainless steel center section that was 5 cm long and had an internal diameter of 1.2 cm, and two stainless steel end sections that were each 10 cm long and had internal diameters of 4 mm. The ends of the center section were threaded and connected to fluted adapters, 2.5 cm long, which were attached to the end sections with rubber tubing. A carrier strip with treated spores was placed within the center section.

One set of devices was placed in an instrument tray and exposed to a full cycle of a hydrogen peroxide plasma sterilization procedure at 45–55° C. in a STERRAD™ 100SI GMP Sterilizer, obtained from Advanced Sterilization Products Co., Irvine, Calif. During the sterilization procedure a vacuum was drawn in the sterilization chamber for 5–6 minutes until the pressure was reduced to 300 mTorr. A 1.8 ml aliquot of an aqueous solution of 58–60% hydrogen peroxide was then injected into the sterilization chamber over a period of about 6 minutes, yielding an empty chamber concentration of 6–7 mg/ml hydrogen peroxide, and hydrogen peroxide vapor was allowed to diffuse throughout the chamber for 44 minutes at 6–10 Torr. A vacuum was then drawn, reducing the pressure to 500 mTorr and removing all detectable hydrogen peroxide vapor from the chamber. A plasma phase was then generated in the chamber by emitting an RF power source at 400 watts and 13.56 MHz for about 15–16 minutes at 500 mTorr, after which the chamber was vented for 3–4 minutes until atmospheric pressure was reached in the chamber.

A second set of devices was placed in an instrument tray and exposed to a partial cycle of a hydrogen peroxide plasma sterilization procedure at 45–55° C. in the STERRAD™ 100SI GMP Sterilizer. In the partial cycle, hydrogen peroxide vapor was allowed to diffuse throughout the chamber for only 9 minutes, as compared to the much longer period of diffusion in the full cycle. Otherwise the partial cycle and the full cycle were the same.

After exposure to the sterilization procedure the test packs, sterilization indicators and laboratory lumen challenge devices were removed from the sterilizer, and the sterilization indicators were removed from the test packs. The carrier strip was aseptically removed from the experimental lumen challenge device and combined with the other components necessary to make a sterilization indicator, as described above, identical to the sterilization indicators used in the test packs. The inner containers of the sterilization indicators containing the enzyme substrate and nutrient medium were then crushed. The indicators were then incubated at 60° C. and examined for fluorescence after 5 hours using a 3M™ ATTEST™ Model 190 Rapid Autoreader, commercially available from 3M Company, St. Paul, Minn. Additionally, spore growth, as indicated by a color change from purple to yellow, was determined visually after 168 hours of incubation.

The number of growth positive indicators detected after 168 hours of incubation is recorded in Table 10. The number of fluorescent positives detected after 5 hours is also recorded in Table 10.

The fractional cycle data in Table 10 indicates that the six inch, nine inch and twelve inch lumen-challenge test packs of the invention provide a challenge to hydrogen peroxide plasma sterilization procedures that is greater than the challenge provided by sterilization indicators exposed without the test packs, and that the non-challenge test pack of the invention provides a challenge that is equivalent to that of a sterilization indicator exposed without a test pack.

TABLE 10 FRACTIONAL CYCLE FULL CYCLE GROWTH GROWTH TOTAL FLUORESCENCE - READOUT - TOTAL FLUORESCENCE - READOUT - DEVICE EXPOSED 5 HOURS 7 DAYS EXPOSED 5 HOURS 7 DAYS 12 in. lumen test pack 1 1 1 1 0 0  9 in. lumen test pack 1 1 1 1 0 0  6 in. lumen test pack 1 1 1 1 0 0  3 in. lumen test pack 1 0 0 1 0 0 Sterilization indicator 1 0 0 1 0 0 Laboratory lumen 1 1 1 1 0 0 challenge device Non-challenge test pack 1 0 0 1 0 0 

1. A sterilization test pack, comprising: (a) a tray for holding a sterilization indicator, said tray comprising an elevated rim surface defining the perimeter of the tray and a recessed trough for receiving a sterilization indicator, said rim surface including a groove of a defined length and cross-sectional area extending through the rim to the recessed trough; (b) a sterilization indicator within the recessed trough of the tray, for testing the effectiveness of a sterilization procedure; and (c) a lid associated with the rim surface of the tray, said lid forming a substantially sterilant-impermeable seal with the rim surface, and said lid forming a channel with the groove in the tray, such that sterilant may enter the tray through the channel and contact the sterilization indicator.
 2. The sterilization test pack according to claim 1 wherein the sterilization indicator comprises a source of an active enzyme.
 3. The sterilization test pack according to claim 2 wherein the source of an active enzyme is a microorganism.
 4. The sterilization test pack according to claim 3 wherein the microorganism is Bacillus subtilis spores.
 5. The sterilization test pack according to claim 3 wherein the microorganism is Bacillus stearothermophilus spores.
 6. The sterilization test pack according to claim 2 wherein the source of an active enzyme is a purified enzyme.
 7. The sterilization test pack according to claim 1 wherein the sterilization indicator comprises: (i) a compressible outer container having at least one opening to allow sterilant to enter the compressible outer container during the sterilization procedure; (ii) a source of an active enzyme contained within the outer container, the enzyme having an enzyme activity that is correlated with the survival of at least one test microorganism commonly used to monitor the effectiveness of a sterilization procedure, wherein the enzyme is substantially inactivated by a sterilization procedure that is lethal to the test microorganism, but wherein the enzyme may not be substantially inactivated by a sterilization procedure that is sublethal to the test microorganism; and (iii) a breakable inner container within the outer container that is impermeable to the sterilant used in the sterilization procedure and that contains a substrate, wherein the inner container is breakable to allow the substrate to contact the enzyme, to form a detectable enzyme-modified product when the sterilization procedure is sublethal to the test organism.
 8. The sterilization test pack according to claim 1 wherein said sterilization procedure employs one or more of sterilants selected from the group consisting of steam, hydrogen peroxide, hydrogen peroxide plasma, ethylene oxide gas, dry heat, propylene oxide gas, methyl bromide, chlorine dioxide, formaldehyde and peracetic acid.
 9. A sterilization test pack according to claim 1 wherein the source of active enzyme comprises an interactive enzyme system and wherein said sterilization indicator further comprises one or more enzyme indicator reagents contained in a chamber which is in fluid communication with the source of active enzyme and which is initially sealed but when unsealed allows the enzyme indicator reagents to contact the source of active enzyme to provide an indication of sterilization.
 10. A sterilization test pack according to claim 1 wherein the rim surface further includes a plurality of grooves, each groove of a defined length and cross-sectional area extending through the rim to the recessed trough; the lid forming a plurality of channels with the grooves in the tray, such that sterilant may enter the tray through the channels and contact the sterilization indicator.
 11. A sterilization test pack according to claim 1 wherein the sterilization test pack is a non-challenge test pack for testing the effectiveness of a hydrogen peroxide plasma sterilization procedure, the sterilization indicator comprising: (a) a source of active enzyme having an enzyme activity that is correlated with the survival of at least one test microorganism commonly used to monitor the effectiveness of a sterilization procedure, wherein the enzyme is substantially inactivated by a sterilization procedure that is lethal to the test microorganism, but wherein the enzyme may not be substantially inactivated by a sterilization procedure that is sublethal to the test microorganism; (b) a sterilant-resistant chemical associated with the source of active enzyme in such a manner that the active enzyme is more resistant to inactivation by a hydrogen peroxide plasma sterilization procedure than it would be if it were not associated with the sterilant resistant chemical; and (c) a substrate that reacts with the active enzyme to form an enzyme-modified product that provides a detectable indication of the failure of the sterilization procedure.
 12. A sterilization test pack according to claim 11, wherein the sterilant-resistant chemical is a compound selected from the group consisting of decaglyceryl decaoleate, decaglycerol pentaoleate, tetraglycerol monooleate, decagLyceryl tri-oleate, decaglycerol hexaoleate, hexaglycerol dioleate, polyoxyethylene (60) glycerol monostearate, polyoxyethylene (20) sorbiatan monostearate, and hexaglyn di-stearate, and mixtures of two or more members of the group.
 13. A sterilization test pack according to claim 11 wherein the sterilization test pack is a non-challenge test pack for testing the effectiveness of a hydrogen peroxide plasma sterilization procedure, the sterilization indicator further comprising: (a) a compressible outer container having at least one opening to allow sterilant to enter the outer container during the sterilization procedure, the source of active enzyme contained within the outer container; and (b) a breakable inner container within the outer container that is impermeable to the sterilant used in the sterilization procedure and that contains the substrate, wherein the inner container is adapted so that it may be broken by compressing the outer container to allow the substrate to contact and react with the active enzyme to form the enzyme-modified product.
 14. A sterilization test pack according to claim 13, wherein the sterilant-resistant chemical is a compound selected from the group consisting of decaglyceryl decaoleate, decaglycerol pentaoleate, tetraglycerol monooleate, decaglyceryl tri-oleate, decaglycerol hexaoleate, hexaglycerol dioleate, polyoxyethylene (60) glycerol monostearate, polyoxyethylene (20) sorbiatan monostearate, and hexaglyn di-stearate, and mixtures of two or more members of the group.
 15. A sterilization test pack according to claim 11 wherein the channel is a lumen path and the sterilization test pack is a lumen-challenge test pack for testing the effectiveness of a hydrogen peroxide plasma sterilization procedure.
 16. A sterilization test pack according to claim 15, wherein the sterilant-resistant chemical is a compound selected from the group consisting of decaglyceryl decaoleate, decaglycerol pentaoleate, tetraglycerol monooleate, decaglyceryl tri-oleate, decaglycerol hexaoleate, hexaglycerol dioleate, polyoxyethylene (60) glycerol monostearate, polyoxyethylene (20) sorbitan monostearate, and hexaglyn di-stearate, and mixtures of two or more members of the group.
 17. A sterilization test pack according to claim 16, further comprising a sterilant barrier positioned within the recessed trough over the sterilization indicator.
 18. A sterilization test pack according to claim 16, wherein the defined length of the lumen path is approximately 12 inches (30.48 cm) and the defined cross-sectional area of the lumen path is approximately the cross-sectional area of a circle having a diameter of 0.25 inches (0.635 cm).
 19. A sterilization test pack according to claim 16, wherein the lumen path is generally in a “Z”—type configuration.
 20. A sterilization test pack according to claim 19, wherein the defined length of the lumen path is approximately 59 inches (150 cm) and the defined cross-sectional area of the lumen path is approximately the cross-sectional area of a circle having a diameter of about 0.2 inch (5 mm).
 21. A sterilization test pack according to claim 19, further comprising a sterilant barrier in the recessed trough over the sterilization indicator.
 22. A sterilization test pack, comprising: (a) a first chamber; (b) an enzymatic indicator within the first chamber; (c) a lumen in fluid communication with the chamber and the enzymatic indicator within the chamber, the lumen comprising a hollow tube of predetermined length and cross-sectional area; (d) a second chamber and an indicator reagent mixture, the second chamber in fluid communication with the first chamber so that the indicator reagent mixture may be brought into contact with the enzymatic indicator after a sterilization cycle is complete.
 23. A sterilization test pack, comprising: (a) a tray for holding a sterilization indicator, said tray comprising a recessed trough for receiving a sterilization indicator; (b) a sterilization indicator within the recessed trough of the tray, for testing the effectiveness of a sterilization procedure; (c) a lid associated with the rim surface of the tray covering the recessed trough and the sterilization indicator, said lid comprising a material that is penetrable by a sterilant, such that sterilant may enter the recessed trough through the lid; and (d) A sterilant barrier within the recessed trough. 